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ABSTRACT 
Elizabeth H. Andersen: Convergence of Aberrant Electrophysiological Correlates of Salience, Affective 
Processing and Stress Reactivity in Patients with Schizophrenia. 
(Under the direction of Aysenil Belger) 
 
 
Patients with schizophrenia exhibit debilitating deficits in attention and affective processing, which 
are often resistant to treatment and associated with poor functional outcomes. Attentional and affective 
processing relies on a distributed neural network of fronto-limbic circuits, which enable cognitive control 
and affective processing, and assist in their interaction to regulate emotional responses. Despite evidence 
of intact affective valence processing, schizophrenia patients are often unable to employ cognitive change 
strategies to reduce attentional capture by emotionally salient stimuli, or modulate neurophysiological 
responses to aversive stimuli. Aberrant neurophysiological correlates of orienting to task-relevant 
emotional stimuli are also present in unaffected first-degree relatives of schizophrenia patients, 
suggesting they may represent vulnerability markers. However, less is known about the attentional 
processing of emotionally salient, task-irrelevant information in these groups, which is examined in 
Experiment 1 (Chapter 2). Results suggest that despite intact novelty detection, schizophrenia patients 
and relatives shared deficiencies in attentional processing of emotionally salient information. First-degree 
relatives exhibited a unique enhancement of the electrophysiological correlate underlying salience 
evaluation, possibly indicating a compensatory engagement of neural circuitry.   
While fronto-limbic circuits are fundamental for affective processing and its modulation by higher 
order cognitive control, this network also plays a critical role in stress regulation, and is disproportionally 
affected by the deleterious effects of stress. To understand the efficiency and resilience of fronto-limbic 
circuitry in adapting and recovering from stress exposure in schizophrenia, Experiment 2 (Chapter 3) 
investigated the effect of an acute experimental psychosocial stressor on neurophysiological indices of 
fronto-limbic-mediated emotional regulation processes. Results suggest that stress exposure modified 
electrophysiological correlates of affective processing in patients and controls. Furthermore, patients 
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demonstrated aberrant fronto-limbic oscillatory indices of affective processing, as indicated by 
exaggerated neural excitability and inefficient frontal cognitive control, and maladaptive stress function. 
This imbalance between heightened neural responsivity and inefficient frontal regulation may reflect an 
atypical arousal state that may in turn interfere with fronto-limbic processing and promote 
symptomatology. Elucidating the neurophysiological correlates underlying salience detection, affective 
processing, and their modification by stress, will be crucial for identifying vulnerability markers, and for 
developing innovative treatment strategies targeting the fronto-limbic circuitry to relieve psychopathology.  
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PREFACE 
Chapter 1 
 Chapter 1 is an introduction to the topics of cognitive and affective salience processing, fronto-
limbic-mediated stress and emotion regulation, the interaction between stress and neurophysiological 
correlates of affective processing, and how these processes are disrupted in schizophrenia. It provides 
the background and justification for the two projects presented in Chapters 2 and 3. 
Chapter 2 
Chapter 2.2 was published in the Clinical EEG and Neuroscience journal (Andersen et al., 2016), 
and formatted to meet the editing standards while keeping the integrity of the manuscript intact, per the 
request of Sage Publishing. In addition to performing the analyses and interpreting the results, I drafted 
the manuscript and critically revised the manuscript with help from the other authors.  
Chapter 3 
Chapter 3 is a manuscript in preparation. I administered the clinical and neurocognitive interviews 
and assessments, collected the EEG and ECG data, and performed the analyses.  
Chapter 4 
 Chapter 4 is the Conclusions chapter, where I summarize important findings, discuss implications 
and significance, and propose future directions. 
 
To prevent redundancy, all references are compiled at the end.
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CHAPTER 1: INTRODUCTION 
1.1 Clinical Overview of Schizophrenia 
Introduction  
 Schizophrenia is a complex heterogeneous disorder with dynamic symptom manifestations 
spanning cognitive, psychological and behavioral processing domains. As the most common type of 
psychosis, schizophrenia affects twenty-one million people worldwide (World Health Organization [WHO]) 
and represents an overwhelming economic burden on society (Chaiyakunapruk et al., 2016). It is 
recognized as a chronic and severe mental illness, characterized by debilitating disruptions in 
disorganized thinking and behavior, distortions of reality, and profound deviations in cognitive and 
affective function (American Psychiatric Association, 2013). Patients experience periods of remission and 
relapse throughout their lifetime, with some individuals experiencing intermittent symptoms and some 
following a course of progressive deterioration. The Diagnostic and Statistical Manual of Mental 
Disorders, 5th Edition (DSM-V) criteria for a schizophrenia diagnosis involves persistent symptoms in two 
of five symptom domains, including delusions, hallucinations, disorganized speech, disorganized behavior 
and negative symptoms. Patients diagnosed with schizoaffective disorder experience depression or 
bipolar symptoms in parallel with schizophrenia symptoms, while a schizophreniform diagnosis is 
dependent on symptoms lasting less than six months. Symptoms of schizophrenia typically emerge 
during young adulthood (18-35), with approximately 1.4:1 incidence ratio for males and females and a 
female dominated older onset (Abel et al., 2010). While female schizophrenia patients express greater 
depression symptoms, males typically experience heightened negative symptoms contributing to a more 
severe course of illness.  
Neurobiology of Schizophrenia and Potential Risk Factors  
 Schizophrenia results from a combination of genetic and environmental insults, which through 
altered signaling pathways, are thought to cause reductions in dendritic spine density (Glantz and Lewis, 
2000), deficiencies in synaptic transmission (Yin et al., 2012) and ultimately, compromise the construction 
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of neural circuitry (Garey, 2010; Penzes et al., 2011). The cortical deterioration observed in schizophrenia 
is accompanied by a collection of symptoms encompassing an extensive range of behavioral and 
cognitive abnormalities. Nevertheless, schizophrenia is first and foremost an information processing 
disorder in which patients experience a notable decline in numerous domains of cognition (Aas et al., 
2014), including attention (Cornblatt and Erlenmeyer-Kimling, 1985), working memory (Manoach, 2003), 
response selection and inhibition (Kiehl et al., 2000), and attribution of salience (Kapur, 2003). 
Schizophrenia patients typically experience their first psychotic episode during late adolescence or early 
adulthood, consistent with the significant neural network refinement that occurs during this period 
(Penzes et al., 2011). As a neurodevelopmental disorder, environmental factors during fetal life are 
proposed to modify neurodevelopmental trajectories and promote the manifestation of symptoms during 
adolescence and adulthood (Wójciak et al., 2016). The following sections summarize the pertinent neural 
mechanisms promoting the pathophysiology of schizophrenia, including genetic and environmental 
interactions, disruptions in neurotransmitter transmission, and structural and functional brain 
abnormalities. 
Environment 
A convergence of environment and genetic influences is thought to promote vulnerability for 
psychosis (Caspi and Moffitt, 2006). Early developmental insults, including infections in utero (i.e., rubella, 
influenza, and poliovirus) (Brown and Susser, 2002) and increased prenatal stress, may disrupt the 
maternal cytokine response leading to obstetric complications in the mother (Patterson, 2002), which are 
thought to predispose vulnerability for schizophrenia (Ross et al., 2006). These early neurodevelopmental 
lesions may establish vulnerability to atypical late neurodevelopmental processes which interact with 
environmental factors, including social adversity accompanying immigration (Weiser et al., 2008), 
urbanicity (Krabbendam, 2005), season of birth (Mortensen et al., 1999), and exposure to psychoactive 
substances such as cannabis (Arseneault et al., 2002), to promote the emergence of psychosis (Pantelis, 
2005). While numerous environmental influences have been proposed to contribute to the manifestation 
of schizophrenia, the validity of the claims remains inconclusive. Nevertheless, genetic and environmental 
influences likely play a synergistic role in promoting disease onset through the genetic control of 
sensitivity to the environment.  
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Stress aggravates synaptic pathologies observed in schizophrenia and is considered a significant 
environmental trigger in the etiology of schizophrenia (Corcoran et al., 2003). A more in depth description 
of the stress system and implications of stress in psychosis can be found in section 1.3. Briefly, the 
cascade of events following stress exposure stimulates structural changes in the brain, including reduced 
dendritic arborization and spine density (Radley, 2005), and exposure to repeated, chronic stress 
associated with extreme life events, such as childhood trauma, may provoke the development of 
psychotic symptoms (Liston et al., 2009). Stress interferes with already vulnerable circuitry in 
schizophrenia patients to intensify cortical atrophy and threaten neural network integrity (Arnsten, 2011). 
Because prefrontal cortical circuits are disproportionately affected by the stress-induced cortical 
disturbances, processes governed by the prefrontal cortex, including working memory, attentional control, 
and behavioral flexibility are particularly susceptible to disruption in patients (Arnsten, 2009, 2011). Given 
the substantial neural modifications and disruptions in cognitive processes inflicted by stress exposure, it 
is not surprising that stress is considered a precipitating factor for psychosis in vulnerable individuals.  
Disruptions in Neurotransmitter Transmission 
Hyperdopaminergic transmission is thought to play a pivotal role in the etiology of schizophrenia 
and is considered one of the most prevailing theories in psychiatry (Howes and Kapur, 2009). The 
dopamine hypothesis of schizophrenia emerged concurrently with the introduction of the conventional 
antipsychotic drugs which target the D2 dopamine receptor subtype and were found to alleviate positive 
symptoms. Moreover, psychostimulants that trigger dopamine release cause psychosis symptoms or 
exacerbate symptoms in patients (Ross et al., 2006). Studies implementing positron emission 
tomography (PET) report that patients exhibit presynaptic dysregulation of dopamine, with increased 
dopamine release in response to impulse and elevated dopamine synthesis, and confirm that the 
hyperdopaminergic state is associated with psychotic symptoms in patients (Kapur, 2003; Soares and 
Innis, 1999). Furthermore, genome-wide association studies (GWAS) have identified the D2 receptor 
gene (DRD2) as a potential candidate gene of interest in schizophrenia, further signifying a fundamental 
role of dopamine in the pathophysiology of schizophrenia. 
However, antipsychotic drugs targeting the dopamine D2 receptor are only minimally effective in 
relieving symptomatology in the majority of schizophrenia patients, suggesting that dopamine is only a 
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small piece of the puzzle. In addition to atypical dopamine activity, disruptions in glutamatergic 
transmission may underlie prominent symptoms of schizophrenia. Proton magnetic resonance imaging 
(H-MRS) has permitted the study of glutamate function in vivo in schizophrenia patients by measuring 
glutamate and its metabolites (Poels et al., 2014). Aberrant glutamate activity and hypofunction at N-
methyl-D-aspartate (NMDA) and metabotropic glutamate receptors (mGluRs) resulting in elevated 
glutamate may also contribute to the pathophysiology of schizophrenia, as phencyclidine (PCP) and 
ketamine block NMDA receptors and produce schizophrenia-like psychotic symptoms (Coyle, 2006).  
Furthermore, while deficiencies in inhibitory gamma-Aminobutyric acid (GABA) neurotransmission 
have been associated with cognitive dysfunction and have a proposed role in dopamine regulation, the 
influence of GABA in the neuropathology of schizophrenia remains controversial (Chiapponi et al., 2016). 
The integration and synergistic interaction of neurotransmitter systems underlies the neurophysiology of 
schizophrenia and motivates a circuit based framework, systems-level approach to understanding 
schizophrenia (Lisman et al., 2008).  
Structural Brain Abnormalities in Schizophrenia 
Global deficits in structural brain morphology have been reported in schizophrenia. Early 
structural MRI and computed tomography (CT) studies of schizophrenia confirmed post-mortem findings 
of a widening of lateral and third ventricles in patients, though these findings are not specific to 
schizophrenia (Ross et al., 2006). Cortical atrophy is consistently observed in schizophrenia patients, with 
dramatic reductions in frontal lobe, amygdala, insula, thalamus and hippocampal gray matter volume 
(Wójciak et al., 2016), and gray matter may decline with illness progression (Haijma et al., 2013). 
Furthermore, a disproportionate deterioration of frontal neural integrity, particularly the dorsal lateral 
prefrontal cortex (DLPFC), and frontal network architecture is thought to underlie devastating 
psychological, cognitive and behavioral symptom pathology in schizophrenia patients (Arnsten, 2011; 
Weinberger, 1987).  
Schizophrenia as a Disconnection Syndrome 
Schizophrenia can be appreciated as a disconnection syndrome, with vast disruptions in efficient 
coordination and integration of neural networks (Friston, 1999, 2011). With recent advances in imaging 
technology, researchers can expand beyond the concentration on distributed anatomical abnormalities, to 
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elucidating the compromised structural and functional integrity of neural network construction subserving 
schizophrenia. Anatomical connectivity can be assessed using diffusion tensor imaging (DTI), which 
concentrates on the fractional anisotrophy (FA) metric to evaluate microstructural properties of white 
matter tracts. DTI studies have revealed that patients with schizophrenia demonstrate reduced FA in 
frontal and temporal lobes, along with aberrations within the fiber bundles connecting these regions 
(Wheeler and Voineskos, 2014), suggesting alterations in structural connectivity in schizophrenia. 
In addition to structural connectivity assessments using DTI, functional MRI studies are useful for 
investigating functional connectivity among brain regions by assessing synchronized blood oxygenation 
levels, an indirect measure of functional integration. The inefficiency of network connectivity and 
functional integration, especially between frontotemporal brain regions, is a fundamental feature of 
schizophrenia, with hypo and hyper task-related connectivity reported (Friston, 2011; Lynall et al., 2010). 
Aberrant activity in the default mode network (DMN), which is active during rest and suppressed during 
attention-demanding tasks, is one of the most robust findings of network disruptions in schizophrenia, and 
impaired DMN suppression is related to abnormalities in neural networks associated with language, 
attention, and working memory (Fitzsimmons et al., 2013; Garrity et al., 2007).  
Along with neuroimaging studies, EEG measures of oscillatory activity offer valuable insight into 
the integrity of functional networks, as the integration of information among distributed brain regions and 
efficiency of connections relies on oscillations and their synchronization. Oscillatory indices of cognitive 
and affective processing are disrupted in patients with schizophrenia, and provide additional evidence of 
deficient network activity and dysconnectivity. Measurement and interpretation of neural oscillatory 
activity is described in more detail in section 1.2. 
Disparities in Treatment Efficacy and Symptom Management  
 The combination of pharmacotherapy, along with psychosocial and psychotherapeutic 
interventions, is often the most effective method to ameliorate symptoms of schizophrenia. However, 
pharmacological agents have only progressed modestly since the first antipsychotic medication was 
introduced 60 years ago, and offer minimal symptom relief with considerable adverse side-effects 
(Bruijnzeel et al., 2014; Ross et al., 2006). Consequently, advancing the understanding of the 
neurobiological correlates underlying schizophrenia is critical for improving illness prognosis. While anti-
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psychotic medications targeting D2 dopamine receptors are typically effective at dampening positive and 
disorganization symptoms, the side-effects are sometimes intolerable and lead to reduced medication 
compliance. Furthermore, these first-generation drugs, including chlorpromazine and haloperidol, 
introduce devastating neurological side effects such as tremor, rigidity, dystonia and dyskinesia, along 
with metabolic and gastrointestinal adverse effects. In addition to targeting the D2 dopamine receptors, 
second generation antipsychotics (atypical), including clozapine and olanzapine, block serotonin 5-
hydroxytryptamine 2A (5HT2A) receptors and have demonstrated efficacy at minimizing the neurologic 
side effects; however, they are not free of adverse side-effects and are associated with substantial weight 
gain and risk for type-II diabetes (Bruijnzeel et al., 2014). With the exception of clozapine, which has been 
shown to be more effective in reducing negative symptoms, there are no major differences in efficacy 
between first and second generation antipsychotics. 
Negative Symptoms and Treatment Considerations 
In addition to the more recognized positive symptoms such as hallucinations and delusions, 
schizophrenia patients experience a debilitating collection of negative symptoms, including blunted 
expression of emotion, diminished participation in interpersonal relationships, apathy, avolition and 
anhedonia which are less responsive to current psychopharmacological methods and are associated with 
a poor functional outcome (Erhart et al., 2006; Green et al., 2004; Williams et al., 2008). Psychosocial 
therapies, including cognitive behavioral therapy (CBT), social skills training, family psychoeducation, 
assertive community treatment and supported employment are valuable treatment options for targeting 
the persistent negative symptoms to improve illness prognosis and quality of life (Kreyenbuhl et al., 
2010). More recently, repetitive transcranial magnetic stimulation to the DLPFC has demonstrated some 
efficacy in improving cognitive function in patients with schizophrenia (Barr et al., 2013). As antipsychotic 
drugs blocking dopaminergic activity are disproportionately effective at ameliorating positive symptoms 
rather than negative symptoms, a network pharmacological approach, or devising drugs that act on 
multiple targets simultaneously rather than single-target agents, is proposed to more adequately address 
the large-scale brain network dysfunction observed in schizophrenia (Hopkins, 2007; Kapur, 2003). 
Advancing treatment approaches for cognitive and emotional symptoms of schizophrenia relies on 
elucidating the molecular, cellular and systems-level pathogenesis of schizophrenia. With stagnant 
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pharmacological treatment progression and only partially effective and intolerable medications available, 
identifying novel endophenotypes and treatment targets is critical.  
Prognosis and Quality of Life 
Schizophrenia is a chronic debilitating disorder that has profound psychological, behavioral, 
emotional and financial impact on the individual and family. Cognitive and negative symptoms, along with 
poor hygiene and low education levels, interfere with patients’ ability to live productive and meaningful 
lives and often promote occupational and social dysfunction (Bobes et al., 2007). Patients tend to self-
medicate with drugs and alcohol, which along with comorbid medical conditions including obesity, 
diabetes, hypertension and coronary heart disease, contribute to an abbreviated life span. Extensive 
support and supervised housing is required, adding to the financial burden on the patients and their 
families (Kitchen et al., 2012). With this dismal prognosis, advancing the understanding of the 
pathophysiological mechanisms promoting vulnerability and neurobiological correlates underlying 
schizophrenia is crucial for devising more effective treatment approaches and improving the quality of life 
for patients with schizophrenia.  
1.2 Schizophrenia as a Dysregulated Salience Syndrome 
Introduction 
Salience processing involves the reactive cognitive elaboration of unique stimuli or stimulus 
features which facilitates directed attention and goal-oriented motivational behaviors (Kapur, 2003). The 
convergence of psychological state, previous experiences, goals, and autonomic and homeostatic 
functions of the brain influence the perception of a stimulus as “salient”. The emotional response to novel 
salient stimuli is context dependent and malleable in order to adapt to situational demands. Inappropriate 
attribution of salience and aberrant perceptual integration are proposed to subserve clinically relevant 
domains of cognitive and affective processing.  
While schizophrenia patients typically exhibit clinical symptoms of attenuated outward expression 
of emotions, or blunted affect, experience a diminished capacity for pleasurable or hedonic experiences, 
anhedonia, and report an enhanced experience of aversive emotion, patients generally present preserved 
“in-the-moment” responses to emotional stimuli, with relatively appropriate subjective ratings of hedonic 
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reactions to evocative stimuli in laboratory settings (Cohen and Minor, 2008; Horan et al., 2010; Kring and 
Moran, 2008; Strauss and Gold, 2012). Nevertheless, patients have difficultly disengaging attention from 
unpleasant environmental cues, demonstrate exaggerated devotion of attention to negative stimuli, and 
exhibit both hedonic and aversive emotions when exposed to positive and neutral stimuli (Cohen and 
Minor, 2008). The inappropriate salience attribution, impaired sensory filtering and elevated reactivity to 
irrelevant neutral information observed in patients (Anticevic and Corlett, 2012) may promote disruptions 
in response selection and regulating negative emotional responses, further exasperating negative 
symptom severity (Strauss et al., 2011).  
Aberrant salience impacts the development and maintenance of psychotic symptoms through 
insula dysfunction and atypical dopaminergic transmission. Appropriate salience attribution is critical for 
the selection of task-relevant information, and involuntary orientation to salient, motivationally-relevant 
and potentially significant stimuli in the sensory environment. Disruptions in salience attribution interfere 
with attentional and cognitive processing of emotional information, suggesting that abnormalities in 
affective processing and regulation may revolve around a central deficit in salience processing. The 
following sections describe the neurobiological correlates of salience processing, including a discussion 
of the insula-centered salience network, dopamine transmission, and how these systems are disrupted in 
psychosis. In addition, the utility of electroencephalography (EEG) in elucidating salience and affective 
processing disparities in patients with schizophrenia is discussed.   
Neural Indices of Salience and Affective Processing  
Efficient attention and response selection, reliant on appropriate salience attribution, is critical for 
adapting to environmental demands and optimizing behavior and response selection. A negativity bias 
has been proposed to explain the exaggerated attention and affective response to emotionally salient, 
aversive stimuli. This emotional processing disparity is thought to serve an evolutionary role to allow 
individuals to exert more energy in dangerous circumstances and prioritize their attention to best adapt 
and survive their environment (Ito and Larsen, 1998). However, sometimes it is necessary to prioritize 
alternative cognitive resources without affective interference. Consequently, the disproportionate 
emotional response for aversive stimuli can be downregulated using emotion regulation strategies to 
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optimize behavior. The down-regulation of the emotional response can be achieved by implementing 
antecedent-focused strategies, such as cognitive reappraisal, or response-focused strategies, including 
expressive suppression (Goldin et al., 2008). Antecedent-focused strategies involve modifying internal 
(e.g., increasing or decreasing certain thoughts) or external (e.g., physical environment where emotions 
are more likely to occur) emotion eliciting factors prior to the emotion being experienced, and by changing 
the way evocative stimuli are appraised (i.e., directing attention to certain features of the environment, or 
framing the environment in a positive or negative emotional context) (Gross and Muñoz, 1995). While 
antecedent-focused strategies can manipulate both the experience and expression of emotion, response-
focused strategies, such as masking sadness with a smile, only impact the emotional expression, and are 
therefore less effective in generating ideal emotional outcomes (Livingstone et al., 2009). 
The successful implementation of emotion regulation strategies requires the enhanced 
engagement of frontal executive control regions, including prefrontal cortex (PFC) and anterior cingulate 
cortex (ACC), and the simultaneous suppression of ventral affective limbic regions, including amygdala 
and insula, to manipulate an emotional response (Goldin et al., 2008; Ochsner et al., 2002, 2004; Phan et 
al., 2005). In response to non-emotional task relevant stimuli, top-down frontoparietal neural networks are 
recruited, while ventral limbic regions are simultaneously suppressed to optimize task-related cognitive 
resources and prevent affective interference. Patients, however, are unable to maintain an appropriate 
balance between the recruitment of frontal attentional networks and engagement of affective limbic 
networks, resulting in compromised attentional processing and exaggerated affective interference 
(Dichter et al., 2010). A disruption in the dynamic reciprocal interaction between frontal executive 
attention networks and limbic affective regulation may promote dysregulation of emotion and attentional 
processing, and interfere with appropriate evaluation of affective stimuli during attention-demanding tasks 
(Dichter et al., 2010). The disproportionate limbic recruitment and failure to shift between attentional and 
affective domains to prioritize attentional resources promote aberrant salience attribution and response 
selection.    
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Salience Network 
The neural processing of salient information synthesizes external sensory and internal emotional 
and visceral state information to motivate attention and behavioral outcomes, and relies on the integration 
of information among distributed regions, comprising a salience network. This salience neural network 
revolves around the insular cortex, along with involvement of the dorsal anterior cingulate cortex (dACC), 
subcortical, and limbic brain regions (Uddin, 2015). The insular cortex is the first cortical target of 
interoceptive and visceromotor inputs, with multiple functionally distinct regions, and plays an integral role 
in integrating information as a hub of the salience network. Additionally, the anterior insular cortex (AIC) 
serves diverse roles in visceral and somatic sensory processing, autonomic regulation of the heart, has 
structural connections with the amygdala, orbitofrontal cortex and ACC, and exerts influence over the 
DMN and central executive network (CEN) (Palaniyappan et al., 2012b; Uddin, 2015).  
Insula and Salience Dysfunction in Schizophrenia 
 Atypical insular connectivity and activation patterns accompany the aberrant salience processing 
observed in schizophrenia. Schizophrenia patients exhibit reduced gray matter volume in bilateral insular 
cortex (Fornito et al., 2009; Glahn et al., 2008; Kasai et al., 2003; Shepherd et al., 2012), and deficient 
activation in response to subjectively salient stimuli and emotion regulation tasks (Li et al., 2010; van der 
Meer et al., 2014). Because of AIC’s crucial role in influencing CEN and DMN network engagement, it is 
proposed that impaired insular connectivity could contribute to the alternative reality experienced by 
patients with the difficulty discriminating between self-generated internal salience and external information 
(Manoliu et al., 2014; Palaniyappan et al., 2012b; Wang et al., 2014; Wylie and Tregellas, 2010). Given 
these essential functions in physiological arousal and stimulus appraisal, deviations in insular connectivity 
and activation may subserve the disruption of salience in neuropsychiatric disorders. 
Role of Dopamine in Aberrant Salience 
Attribution of motivational salience is a critical component of appetitive behavior, reward 
prediction, learning and motivational behaviors (Berridge and Robinson, 1998), and is mediated by the 
dopamine system, which is dysregulated in patients with schizophrenia. The mesolimbic dopaminergic 
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system subserves motivational salience attribution by signifying a neural representation of external stimuli 
as attractive or aversive to promote appropriate cognitive and behavioral actions (Kapur, 2003). 
Consequently, abnormal dopamine transmission, particularly the hyperdopaminergic state observed in 
psychosis, may promote aberrant salience by generating stimulus-independent attribution of motivational 
salience (Kapur, 2003). The inappropriate assignment of valence to external objects and internal 
representations amplifies the significance of unimportant, irrelevant perceptions and ideas which are 
experienced as hallucinations and ultimately result in delusions following cognitive conceptualization of 
the aberrant salience representations (Kapur, 2003; Uddin, 2015). Accordingly, improved salience 
processing accompanies the administration of antipsychotic medications targeting dopaminergic D2 
receptors.  
Electrophysiological Studies of Salience and Affective Processing  
Electroencephalography (EEG) has been extensively used in order to investigate the neural 
correlates of aberrant affective processing and salience in schizophrenia patients because of its superior 
temporal resolution and capacity to differentiate between distinct cognitive and perceptual processing 
dimensions (Hajcak et al., 2010; Luck, 2005; van der Stelt and Belger, 2007). The EEG signal is thought 
to arise from temporally and spatially aligned dipoles of cortical pyramidal neurons which summate, and 
the resulting rhythmic field potentials are recorded from the scalp. From the raw EEG signal, researchers 
can evaluate event-related potentials (ERPs) which are voltage deflections that are time-locked to the 
onset of a stimulus, or further decompose the signal into magnitude and phase information for different 
frequencies to examine multiple layers of parallel processing and characterize changes over time with 
respect to task events. Time-frequency analyses permit the examination of event-related changes in EEG 
power that are time-locked (event-related spectral perturbation (ERSP)) or phase-locked (evoked power 
(EP)) with respect to the event, and intertrial phase coherence (ITC), which assesses event-related phase 
consistency across trials as an index of neural synchrony (Roach and Mathalon, 2008; Uhlhaas and 
Singer, 2006). Examination of oscillations and their synchrony is a valuable tool for probing circuit level 
activity, as synchronized neuronal activity allows for coordinated neural activity and interneuronal 
communication across distributed brain regions. Slow wave frequencies, such as theta, support long 
distance communication between remote brain regions, while fast wave oscillations, including gamma, 
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are more restricted to localized circuits due to conduction properties of the brain (Moran and Hong, 2011). 
The P3 and late positive potential (LPP) ERP components and theta and beta oscillations are particularly 
relevant for studying salience and affective processing and are discussed in the following sections.  
ERP Correlates of Salience and Affective Processing 
The P3 ERP component is thought to reflect the automatic orienting to salient environmental 
information and allocation of attention to task demands (Polich, 2007). Accordingly, deviations in the P3 
amplitude may underlie abnormalities in numerous domains of cognition, including attention, working 
memory, response selection and inhibition, and attribution of salience to task-relevant stimuli exhibited by 
schizophrenia patients. In fact, a diminished P3 ERP amplitude response during auditory and visual 
modalities in schizophrenia patients is one of the most robust, replicated findings in schizophrenia 
research (Kidogami et al., 1991; Mathalon, 2000; Pritchard, 1986; Roth and Cannon, 1972; van der Stelt 
et al., 2004), and has proposed utility in elucidating intermediate neurobiological processes influenced by 
genetic variation (Meyer-Lindenberg and Weinberger, 2006). Emotional, motivationally relevant stimuli 
should automatically capture attention and generate a midline P3a response approximately 300 ms 
following stimulus onset reflecting the attribution of stimulus significance or salience (Johnson, 1984). The 
P3b, on the other hand, is elicited between 300 and 500 ms over medial central and parietal scalp 
locations following target stimulus presentation and can serve as an index for the amount of attention 
devoted to the stimulus event (Falkenstein et al., 1999; Johnson, 1984; Katayama and Polich, 1998; 
Polich, 2007).  
Additionally, the LPP ERP component is elicited between 400 and 1000 ms at midline parietal 
electrode sites following novel, emotionally salient stimuli, and serves as an index for the cognitive 
elaboration of motivationally relevant stimuli, as the LPP amplitude is greater for unpleasant stimuli 
relative to pleasant or neutral stimuli, regardless if the stimuli are relevant to the primary task (Ito et al., 
1998; Hajcak et al., 2010). Successful execution of emotion regulation strategies have been found to alter 
electrophysiological correlates of affective processing, including LPP amplitude and associated neural 
oscillatory activity, to support a more adaptive behavioral response (Ertl et al., 2013; Goldin et al., 2008; 
Hajcak et al., 2010; Kisley et al., 2011; Ochsner et al., 2002, 2004; Phillips et al., 2008; von Scheve, 
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2012). Specifically, it is possible to relieve the heightened LPP response to aversive stimuli by simply 
introducing cognitive framing strategies (i.e., positive or negative contextual cues), thereby assessing a 
key aspect of emotion regulation (Kisley et al., 2011). Furthermore, schizophrenia patients have reported 
using cognitive reappraisal strategies less often (O’Driscoll et al., 2014) and demonstrate neural 
deficiencies in emotion regulation, with diminished PFC activation (Morris et al., 2012) and inability to 
down-regulate the emotional response (LPP amplitude) to unpleasant images using cognitive change 
strategies (Strauss et al., 2013).  
Oscillations and Their Synchronization Underlying Salience and Affective Processing 
Schizophrenia is recognized as having profound disruptions in neural connectivity and can be 
conceptualized as a disconnection syndrome, suggesting that investigating EEG oscillatory activity can 
provide critical information for understanding the neurobiological correlates of symptom pathology. 
Deviations in working memory, attention and affective processing expressed in schizophrenia have been 
connected to widespread deficiencies in oscillatory activity, including activity in theta and beta frequency 
bands (Basar and Guntekin, 2013; Uhlhaas et al., 2008; Uhlhaas and Singer, 2014). A discussion of theta 
and beta oscillations and how they are disrupted in schizophrenia is presented in the following sections.  
Probing Fronto-Limbic Circuitry Using EEG 
Theta oscillatory activity occurs in the frequency range of approximately 4 to 8 Hz, is primarily 
generated by glutamatergic and GABAergic neurons, and is prominent in the hippocampus where it plays 
a pivotal role in locomotion, spatial navigation, and memory. The efficient interaction and integration of 
information between frontal and limbic brain regions can be represented by the synchronization of neural 
oscillations in low frequencies, including theta (Javitt et al., 2008). Therefore, disruptions in low frequency 
oscillations may produce impairments in long-distance functional connectivity between frontal and limbic 
brain regions critical for affective processing (Lesting et al., 2011). Additionally, theta activity supports 
prefrontal cortex dependent top-down cognitive control and working memory function, with increases in 
theta oscillatory activity, localized to midline frontal scalp locations, corresponding to greater task 
demands (Jensen and Tesche, 2002), and the need for cognitive control (Cavanagh and Frank, 2014). An 
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increase in frontal theta activity has also been reported to accompany successful reappraisal of emotional 
events, representing enhanced frontal recruitment (Ertl et al., 2013).  
Atypical Theta Oscillatory Activity in Schizophrenia Patients 
Deficiency in theta activity is proposed to be of particular interest in patients, as theta oscillations 
are prominent in the hippocampus, a brain region that demonstrates volumetric reductions in SCZ 
(Mondelli et al., 2010), and because of theta’s involvement in affective processing, working memory and 
cognitive control, which are all impacted in SCZ (Berger et al., 2016; Schmiedt et al., 2005; Uhlhaas et al., 
2008). In addition, reduced theta coherence between frontal and temporal regions has been shown to be 
associated with auditory hallucinations (Ford et al., 2002).  
Aberrant Beta Oscillatory Activity in Schizophrenia Patients 
 Beta oscillations in frequencies between 12 and 30 Hz are generated by glutamate, N-methyl D-
aspartate (NMDA) and GABAergic systems and are found in all cortical and some subcortical structures, 
including the hippocampus and basal ganglia, where they serve to coordinate motor function, and 
mediate top-down activity in learning, novelty detection, sensory gating and reward evaluation (Uhlhaas 
et al., 2008). Given the dopaminergic modulation of beta activity in the basal ganglia, it is possible that 
dysregulated dopaminergic activity may subserve the deficits in beta synchronization observed in SCZ 
patients. 
Salience Disturbance and Cognitive/Behavioral Consequences 
Disturbances in the salience network, particularly the insula, may promote prodromal symptoms 
such as perceptual and cognitive abnormalities, which progressively decline into distortions of reality, 
aberrant affective processing and disorganization of speech and behavior in established illness 
(Palaniyappan et al., 2012b). Atypical activity in the salience network is not found in first-degree relatives, 
suggesting that environmental insults may trigger the deterioration of salience network architecture and 
function in vulnerable individuals (Palaniyappan et al., 2012a). Consequently, salience network 
dysfunction is a promising therapeutic target to guide treatment approaches and intervention strategies. 
Furthermore, brain network modulation (BNM) is an innovative approach combining network 
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pharmacology to improve plasticity of connections and cognitive training that could enhance salience 
network activity to provide potential symptom relief for patients with schizophrenia (Palaniyappan et al., 
2012b). Mindfulness training (Tang et al., 2012) and neurofeedback (Johnston et al., 2010) strategies 
have also demonstrated efficacy in improving salience network activity and connectivity. Identifying EEG 
correlates of salience network efficiency will provide valuable biomarkers that can be used to test the 
effectiveness of novel treatment strategies and intervention approaches. 
1.3 Fronto-Limbic Circuitry Underlying the Relationship Between                                                
Stress and Affective Processing in Schizophrenia 
Introduction 
The regulation of stress and affective systems both rely on fronto-limbic circuitry. Projections from 
the prefrontal cortex, amygdala, and hippocampus provide feedback for regulating the stress response 
(Herman et al., 2005). These same regions are integral to appropriately processing emotionally salient 
stimuli and regulating affective responses. As a result, the disruptions in fronto-limbic circuitry observed in 
schizophrenia patients may contribute to aberrant stress and affective processing (Dedovic et al., 2009; 
Zhang et al., 2014). Stress exposure disrupts the dynamic balance between frontal and limbic brain 
regions, causing reduced frontal engagement and enhanced recruitment of limbic regions, especially the 
amygdala (van Marle et al., 2010). This in turn heightens the emotional salience and arousal for aversive 
stimuli, causing greater arousal interference on performance, and makes the implementation of emotion 
regulation strategies more challenging (Raio et al., 2013). Stress is proposed as an important 
environmental trigger for psychosis and aberrant stress reactivity may disrupt cognitive treatment efforts 
reliant on fronto-limbic dependent processes (Corcoran et al., 2003; Garner et al., 2011; 
Venkatasubramanian et al., 2010). The interaction between fronto-limbic mediated stress and affective 
processing is described in more detail in the following sections, with particular focus on the hypothalamic-
pituitary-adrenocortical (HPA) axis, the autonomic nervous system, and how these systems are 
dysregulated in patients with schizophrenia. The detrimental effect of stress on the brain and its 
association with psychosis is also discussed. 
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Overview of the Stress Response 
Hypothalamic-Pituitary-Adrenocortical (HPA) Axis 
Exposure to stress, whether it is reactive, anticipatory, physical or psychological, initiates a 
cascade of events to prepare an organism for the perceived increase in demand of cognitive and 
physiological resources (Dedovic et al., 2009; Herman et al., 2005). The activation of the HPA axis 
ultimately releases glucocorticoids to mobilize stored energy, to augment autonomic function, and to 
provide a negative feedback mechanism to restrict the magnitude and duration of glucocorticoid (cortisol) 
release (de Kloet et al., 2005; Herman et al., 2005; Ulrich-Lai and Herman, 2009). In response to stress, 
neurons in the paraventricular nucleus (PVN) of the hypothalamus secrete corticotropin-releasing 
hormone (CRH), as well as other factors including arginine vasopressin (Ulrich-Lai and Herman, 2009). 
Together these hormones act on the anterior pituitary to promote adrenocorticotropic hormone (ACTH) 
secretion, which further stimulates the synthesis and release of glucocorticoids from the adrenal cortex 
(de Kloet et al., 2005; Dedovic et al., 2009; Herman et al., 2005; Ulrich-Lai and Herman, 2009).  
Negative Feedback Systems 
Converging projections from the medial prefrontal cortex (mPFC), amygdala, and hippocampus 
integrate at subcortical relay sites, including the bed nucleus of the stria terminalis (BNST), to dynamically 
coordinate autonomic and neuroendocrine stress responses and accommodate the physical and 
cognitive demands of the stressor (Herman et al., 2005; Ulrich-Lai and Herman, 2009). While the majority 
of limbic projections do not directly innervate the PVN, limbic regions express both glucocorticoid (GR) 
and mineralocorticoid receptors (MR), which permits glucocorticoid-mediated limbic regulation of the HPA 
response (Herman et al., 2005; Ulrich-Lai and Herman, 2009). Stress-induced glucocorticoid inhibition of 
HPA activity relies on glutamatergic innervation of GABAergic neurons in subcortical relay regions, such 
as the BNST, from structures including the hippocampus and prefrontal cortex, to inhibit PVN neurons 
and promote attenuated cortisol release. Conversely, the amygdala, especially medial and central 
amygdaloid nuclei, exerts its effects through GABAergic circuits to disinhibit CRH release and potentiate 
glucocorticoid secretion (Herman et al., 2005). In addition to regulating HPA activity, limbic systems are 
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heavily implicated in the development of maladaptive stress responses and consequently, the 
pathophysiology of psychiatric disorders.  
Autonomic Stress Response 
In addition to the HPA response, the autonomic nervous system (ANS) rapidly responds 
autonomously to stress by mobilizing energy resources, increasing heart rate, and elevating 
catecholamine secretion for immediate assessment and reaction to physiological disruptions in 
homeostasis (Appelhans and Luecken, 2006). The ANS innervates internal organs through the excitatory 
sympathetic “fight or flight” and the inhibitory parasympathetic “rest and digest” systems, which offer 
opposing mechanisms to optimize physiological and behavioral responses (Appelhans and Luecken, 
2006; Porges, 2007). While the sympathetic division responds to stress exposure by increasing heart 
rate, dilating airways to facilitate breathing, and releasing stored energy, the parasympathetic system is 
suppressed to prevent interference of stress-inappropriate processes, such as digestion and urination. 
The parasympathetic (vagal) and sympathetic branches of the ANS exert competing regulatory influences 
on the heart rate by influencing the activity of the sinoatrial ‘pacemaker’ node of the heart. During 
stressful conditions, vagal tone to the sinoatrial pacemaker node of the heart is suppressed or the “vagal 
brake” is removed in order to support mobilization, defensive “flight or fight” strategies, while the vagal 
influence is disinhibited and the vagal brake is maintained or increased to foster calm, engaging social 
behaviors (Porges, 2007). Deficient neural regulation of the vagal brake promotes maladaptive 
physiological reactivity and is proposed to account for compromised social engagement and affect 
expressivity in patients (Porges, 2007). Sympathetic influences, mediated by norepinephrine 
neurotransmission, offer an excitable effect on the sinoatrial node to slowly increase heart rate; whereas, 
the parasympathetic system exerts a rapid inhibitory influence on the heart rate through acetylcholine 
transmission. Consequently, parasympathetic and sympathetic ANS divisions exert antagonistic 
influences on heart rate, differentially regulating the interval between consecutive heartbeats (heart rate 
variability (HRV)), and generating heart rate oscillations at distinct frequencies (Porges, 2007). The rapid 
parasympathetic vagal response is uniquely modified by respiration, with inhalation preventing 
parasympathetic actions and exhaling reinstating parasympathetic influence to reduce heart rate. 
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Respiratory sinus arrhythmia (RSA) refers to the parasympathetic mediated heart rate oscillations in 
synchrony with respiration, reflected in the high-frequency component of HRV, and it is thought to index 
the efficiency of vagal brake regulation (Lewis et al., 2012; Porges, 2007). 
Physiological Arousal and Emotional Response 
Emotion regulation and coping strategies rely on the appropriate management of metabolic 
resources and physiological arousal to initiate situationally-relevant behaviors and emotional responses 
(Appelhans and Luecken, 2006). The assessment of external stimuli is governed by the central autonomic 
network (CAN) comprised of brain regions spanning executive and limbic neural networks (including the 
PFC, ACC, insula, hypothalamus, amygdala, and BNST) along with brainstem regions, which coordinates 
with visceral afferents conveying information about internal physiological state to adjust arousal and 
impact emotional expression. The CAN output is transmitted by the ANS to the sinoatrial node to regulate 
heart rate, reflected in HRV (Appelhans and Luecken, 2006). Furthermore, efficient use of emotion 
regulation and coping strategies have been reported to be associated with higher levels of 
parasympathetic mediated HRV, or RSA (Fabes and Eisenberg, 1997; O’Connor et al., 2002), while lower 
resting RSA levels were related to elevated negative emotional arousal in response to stress (Fabes and 
Eisenberg, 1997). 
Psychophysiological Theories of HRV 
 Two complementary theories are offered to describe the contributions of ANS and neural 
regulation systems in modulating emotional expression and physiological arousal. The polyvagal theory, 
proposed by Porges (2007), is based on an evolutionary framework with three competing stages of ANS. 
The dorsal vagal complex was proposed to be the first to evolve, comprised of a slow responding, 
unmyelinated vagus nerve which supports immobilization and passive avoidance, followed by the 
sympathetic-adrenal system to allow for mobilization and defensive behaviors. Finally, a ventral vagal 
complex evolved with a fast-acting myelinated vagus nerve to withdraw or extend influence on the 
sinoatrial node of the heart, and afferent fibers innervating nuclei of facial and trigeminal nerves, to 
support social communication, and calm, low arousal states. Consistent with the Jacksonian principle of 
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dissolution and response hierarchy, when the ventral vagal complex is insufficient to manage the 
metabolic demand, other lower systems dominate to adapt to the situation (Wiest, 2012). Social behavior 
disturbances, therefore, are proposed to result from a compromised ventral vagal system, resulting in 
phylogenetically older neural system-dominated mobilization or immobilization behaviors, which are 
incompatible with appropriate social engagement (Porges, 2007). In contrast, the neurovisceral 
integration model, introduced by Thayer and colleagues (2000), propose that the CAN is the 
neurophysiological hub of a dynamical system, through which interactions among lower level elements, 
such as valence and arousal, give rise to specific behavioral, cognitive and physiological emotional 
states.  
Studying the Stress Response in Patients 
The stress response can be evaluated experimentally using psychosocial, pharmacological and 
physiological challenges that induce fluctuations in heart rate parameters and hormone release.  
Trier Social Stress Test 
The Trier Social Stress Test (TSST) is a well-established acute psychosocial stressor which has 
been used in diverse populations (with slight modifications) and activates the HPA axis with well-defined 
endocrine, immune and central nervous system stress responses. The TSST combines a public speaking 
task with challenging mental arithmetic (serial subtraction) to reliably induce a moderate stress response 
associated with a subjective negative experience (Allen et al., 2014; Kirschbaum et al., 1993). In 
response to the TSST, elevated proinflammatory cytokine production accompanies HPA activation and 
glucocorticoid release, along with gastrointestinal effects via autonomic innervation. Parasympathetic 
nervous system activity can be assessed using physiological heart rate parameters, including RSA, 
whereas sympathetic nervous system activity can be characterized using alpha-amylase, a salivary 
enzyme which rapidly increases following stress exposure, the galvanic skin response, and plasma 
catecholamine concentration (Nater et al., 2005). Alternatively, the Montreal Imaging Stress Test (MIST) 
is an fMRI compatible psychosocial stressor incorporating negative feedback and mental arithmetic. 
Increased deactivations in hippocampus and increased amygdala activation have been reported following 
MIST exposure (Allen et al., 2014). These psychosocial stressors have demonstrated utility in elucidating 
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the stress response in clinical populations, including schizophrenia (Brenner et al., 2009; Ciufolini et al., 
2014; Foley and Kirschbaum, 2010). 
Cortisol Collection Parameters 
During a stress manipulation, cortisol is typically collected at distinct intervals to capture the 
characteristic stress-induced cortisol response curve. While cortisol can be assayed from cerebral spinal 
fluid (CSF), urine, and plasma, salivary cortisol is the preferred measurement of bioavailable cortisol, 
primarily because it is non-invasive and easily collected in patient populations (Allen et al., 2014). Cortisol 
has a natural diurnal rhythm which peaks 30 minutes upon awakening and plateaus in the early 
afternoon. Taking the natural fluctuations into consideration, experimental assessments of cortisol are 
typically conducted during the early afternoon hours to most accurately evaluate HPA function and stress 
reactivity. In response to an experimental stressor, cortisol peaks approximately 20 minutes following the 
introduction of stress, and recovers back to baseline levels about 70 minutes after the termination of the 
stress manipulation (Allen et al., 2014; Foley and Kirschbaum, 2010). Schizophrenia patients have 
demonstrated a blunted cortisol response in reaction to the TSST (Brenner et al., 2009; Jansen et al., 
1998, 2000).  
Heart Rate Parameters 
The balance of parasympathetic and sympathetic nervous systems and autonomic flexibility can 
be evaluated using heart rate variability measurements, including parasympathetic mediated HRV or RSA 
(Appelhans and Luecken, 2006; Porges, 2007). TSST stress exposure elicits increased heart rate and 
blood pressure while reducing HRV, consistent with reduced HRV supporting mobilization behaviors in 
healthy individuals. Despite reports of resting acute atypical heart rate variability, HRV has not been 
examined in SCZ patients in reaction to the TSST.  
Alternative Stress Induction Protocols 
The TSST is widely used for reliably activating the HPA axis and capturing the stress response; 
however, alternative pharmacological and physiological challenges have also been utilized to induce a 
stress response experimentally. In particular, dexamethasone (dex), a synthetic glucocorticoid, can be 
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administered to study negative feedback to the HPA axis and suppression of cortisol and 
adrenocorticotropic hormone (ACTH) secretion (Allen et al., 2014; Carroll, 1982). The dex test can also 
be combined with corticotrophin releasing hormone (CRH) application for a more sensitive experimental 
approach to elucidate HPA axis function in neuropsychiatric disorders (Heuser et al., 1994). While a large 
release of cortisol and ACTH is prevented following the dex/CRH test in healthy individuals, indicating 
appropriate HPA axis activity, an abnormal dex/CRH test would suggest a failure to suppress cortisol, 
therefore indexing deficiencies in negative feedback mechanisms (Heuser et al., 1994). Additionally, the 
physiological stress response can be examined using the short Synacthen test which involves ACTH 
stimulation to assess HPA axis function at similar time intervals to TSST, and inhaling carbon dioxide is 
used to induce panic attacks and study physiological stress (Abdu et al., 1999). Furthermore, the cold 
pressor task is often used to induce a stress response by submerging the hand in cold water for a couple 
of minutes; however, it has a relatively short stress exposure, assesses pain tolerance in addition to 
stress, and is less efficient at inducing cortisol changes (McRae et al., 2006). Alternatively, a social 
evaluation component can be added to the cold pressor task, or the cold pressor task can be combined 
with the mental arithmetic component of the TSST (e.g., the Maastricht Acute Stress Test) to elicit a more 
robust stress response (Allen et al., 2014).   
Challenging computerized cognitive tasks, including the Stroop task, along with distractors such 
as noise, have also been found to stimulate a stress response (Allen et al., 2014). While public speaking 
tasks and disturbing video clips are reported to elicit a reliable stress response, the combination of public 
speaking and other cognitive challenges or emotion induction procedures are suggested to be more 
effective at maximizing stress reactivity (Allen et al., 2014). Accordingly, the Mannheim Multicomponent 
Stress Test was designed to combine noise, cognitive performance, emotional induction, and the threat of 
losing financial compensation to elicit a stress response. Participants view aversive images while they 
perform serial subtraction test with the threat of reduced payment and increasingly louder levels of white 
noise (Reinhardt et al., 2012). Considering all of the available methods of stress induction, the TSST is 
arguably the most popular psychosocial stressor for it achieves a robust stress outcome without exposing 
the participant to physical discomfort or administering pharmacological manipulations. 
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Stress Cascade and the Affective Pathway to Psychosis 
Effect of Stress on the Brain 
Chronic exposure to stress and associated elevations in cortisol has detrimental effects on neural 
structural and functional integrity. Prefrontal cortical and hippocampal brain regions, which are 
fundamental to the neuropathology of schizophrenia, are disproportionally effected by the deleterious 
effects of stress exposure (Arnsten, 2009). Stress-induced neurotoxicity in the hippocampus and PFC 
causes cell atrophy and loss of glucocorticoid receptors, resulting in impaired cognitive functions reliant 
on these brain regions (Fuchs and Flügge, 2003). Furthermore, rodents with heightened glucocorticoids 
(corticosterone) exhibited diminished neurogenesis (Cameron and Gould, 1994) and weakened long-term 
potentiation (LTP) in the dentate gyrus of the hippocampus (Pavlides et al., 1993), and demonstrated 
behavioral deficits in hippocampal-dependent spatial memory (Luine, 1994). Additionally, endogenous 
(i.e., Cushing’s disease) or exogeneous (experimenter-delivered) high levels of cortisol are associated 
with reduced hippocampal volume and memory function (Belanoff et al., 2001; Lupien et al., 2007), which 
can be reversed with the normalization of cortisol levels (Starkman et al., 1999). The effect of stress on 
volumetric changes observed in neuropsychopathology is further supported by the fact that mental 
disorders with stress as a defining feature, such as post-traumatic stress disorder (PTSD), present with 
reduced hippocampal volume, similar to schizophrenia patients (Bremner et al., 1995). Developmental 
insults may subserve hippocampal dysfunction leading to HPA dysregulation and impaired negative 
feedback, further exasperating stress-induced hippocampal impairment. Stress is also proposed to 
stimulate hyperresponsivity of subcortical dopamine activity through impaired PFC-inhibition and 
disrupted frontal connections with stress-related circuitry (Moghaddam, 2002). 
HPA Dysfunction in Schizophrenia 
Converging evidence points to a relationship between the HPA axis and psychosis, with SCZ 
patients exhibiting elevated baseline diurnal cortisol levels (Garner et al., 2011) and volumetric reductions 
in brain regions important for HPA regulation, including the hippocampus (Mondelli et al., 2010). 
Furthermore, cortisol levels have been associated with SCZ symptom severity (Garner et al., 2011; 
Walder et al., 2000) and high doses of exogenous corticosteroids can promote psychotic symptoms 
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(Buchman, 2001; Warrington and Bostwick, 2006). An impaired stress response may result in chronically 
elevated cortisol levels and heightened negative emotional reactivity, as well as promote cognitive deficits 
and increased symptom severity by modulating vulnerable fronto-limbic circuitry, and associated neural 
synchrony. Schizophrenia patients report greater subjective levels of stress (Horan et al., 2005; Renwick 
et al., 2009), heightened stress sensitivity (Yuii et al., 2007) and emotional reactivity to stressful events 
(Docherty et al., 2009), and appraise positive and negative events as being less well managed and less 
controllable than healthy individuals (Horan et al., 2005). Previous research has established that 
symptom severity and inferior coping tendencies are related to an aberrant stress response (Belvederi 
Murri et al., 2012; Corcoran et al., 2003; Quirin et al., 2011; Walder et al., 2000; Walker et al., 2013), and 
symptom severity has been associated with abnormalities in frontal and limbic brain activation (Goghari et 
al., 2010). 
Stress Influences on Neurophysiology  
Acute stress exposure compromises PFC function, disrupts network connectivity and impairs 
PFC-dependent working memory and underlying neural oscillatory activity. Oscillations underlying fronto-
limbic connectivity, including theta and beta, appear to be most affected by the deleterious effects of 
stress. Frontal theta activity elicited during working memory (Gärtner et al., 2014) and mental arithmetic 
(Gärtner et al., 2015) tasks has been shown to diminish following stress induction using disturbing videos 
with aversive content. Disruptions in frontal theta, and associated frontal neural deficiencies following 
stress exposure, may interfere with the suppression of DMN during cognitive tasks (Broyd et al., 2009; 
Qin et al., 2009). However, stress has also been found to stimulate an increase in theta activity, with 
enhanced theta activity following sleep deprivation (Alonso et al., 2015) and with stressful task complexity 
(Jensen and Tesche, 2002). The differential effects of stress on theta activity may be explained by the 
type of stress exposure, and discrepancies in the analysis of theta oscillatory activity (e.g., whether it was 
time or phase-locked to task events). Furthermore, exposure to acute noise-induced stress impacts EEG 
indices of feedback processing and performance monitoring during a gambling task, with reduced ERP 
amplitudes (feedback-related negativity (FRN) and P3), a smaller increase in theta in response to 
feedback, and a sex-dependent increase in beta activity during the stress condition (Banis et al., 2014).  
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Beta activity has also been found to increase during a stressful Stroop task (Alonso et al., 2015). 
Consistent with enhanced beta activity during stress, Chapotot and colleagues (1998) propose a 
significant coupling between natural cortisol fluctuations and beta power that could potentially coordinate 
the regulation of arousal and alertness. Moreover, the relationship between resting state slow wave 
(theta) and fast wave (beta) oscillatory activity is proposed to underlie PFC network efficiency and be 
useful as a biomarker for PFC-mediated attentional control. Exaggerated limbic activity and weakened 
frontal control is reflected in an increased theta/beta ratio (relatively greater theta than beta activity), and 
is related to a greater decline of subjectively experienced attentional control following an acute 
psychosocial stressor (Putman et al., 2014). Additionally, stress is reported to shift resting frontal EEG 
asymmetry from greater left frontal alpha to predominately right frontal alpha during the high stress 
condition (Lewis et al., 2007), further demonstrating stress induced disruptions of oscillatory activity. 
Fronto-limbic oscillatory indices provide valuable information about the integrity of the fronto-limbic 
circuitry and the resiliency of the system in response to stress. 
Interaction of Stress and Affective Processing 
Emotion regulation strategies rely on fronto-limbic brain regions, which are disproportionately 
susceptible to the deleterious effects of stress (i.e., hippocampus, amygdala, PFC), indicating a critical 
role of stress in modifying emotional responses. Stress exposure interferes with emotion regulation and 
working memory processing by disrupting fronto-limbic circuitry engagement, causing an exaggerated 
recruitment of ventral affective regions and diminished dorsal frontal control (Oei et al., 2012). The shift 
towards a ventral affective dominated response may explain why it is more difficult to disengage from 
emotional images (Kinner et al., 2014) and to utilize emotion regulation strategies to minimize conditioned 
fear responses following stress exposure (Raio et al., 2013). Additionally, the amplified amygdala 
response to negative emotional stimuli, in particular negative facial emotion, may be associated with the 
elevated levels of norepinephrine and cortisol observed during stress (Kukolja et al., 2008). Furthermore, 
chronic stress exposure, such as childhood poverty, may interfere with emotion regulation and underlying 
neural circuitry in adulthood, causing inefficient frontal engagement and suppression of amygdala activity 
during an emotion regulation task (Kim et al., 2013). The interaction of stress and affective processing 
may be modulated by sex, as stress enhances the ability to regulate negative emotions in females 
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(Kinner et al., 2014), who also demonstrate increased limbic, amygdala, and superior temporal gyrus 
(mediating attention) recruitment during stress relative to males (Kogler et al., 2014). However, the threat 
of an acute stressor has also been found to disrupt sensitivity in facial emotion identification to a greater 
extent in females relative to males (DeDora et al., 2011).  
The heightened cortisol levels that accompany stress exposure may aid in suppression and 
reappraisal emotion regulation approaches, and relieve some interference by emotional distractors on 
working memory performance (Lam et al., 2009; Oei et al., 2012). Yet, the advantageous role of cortisol 
in emotion regulation and working memory appears to be sex-dependent (Kinner et al., 2014; Kogler et 
al., 2014; Smeets et al., 2009). Cortisol levels following stress exposure had opposing effects on social 
cognition performance in males and females, as elevated cortisol associated with superior social 
cognition in males and weaker social cognition in females (Smeets et al., 2009).  
While emotion regulation strategies are more difficult to implement under stressful conditions, 
they are essential for controlling the negative reaction to stress. Accordingly, the successful 
implementation of emotion regulation strategies, including attentional control and cognitive reappraisal, 
can promote heightened resilience following stress exposure to protect against the negative outcomes of 
stress (Troy and Mauss, 2011). Considering that subjective ratings of stress can be relieved using 
cognitive strategies reliant on the enhanced engagement of regions involved in working memory (middle 
frontal gyrus) and attention (superior temporal gyrus), and reduced activation of the hippocampus (Kogler 
et al., 2014), the deleterious effects of stress may be ameliorated by improving emotion regulation 
strategies and attentional control.  
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CHAPTER 2: SALIENCE AND AFFECTIVE PROCESSING IN SCHIZOPHRENIA                             
PATIENTS AND FIRST-DEGREE RELATIVES 
2.1 Context 
Despite intact electrophysiological responses to attended evocative, emotional stimuli, it is 
unclear whether schizophrenia patients respond appropriately to extraneous task information or 
motivationally relevant distractor emotional stimuli (Dichter et al., 2010; Horan et al., 2010, 2012). This 
study examined differential electrophysiological responses to task-relevant and irrelevant emotional 
images in schizophrenia patients, first-degree relatives and healthy controls to determine whether 
patients are more susceptible to task interference from irrelevant, salient emotional stimuli. 
Elucidating the pathophysiological mechanisms underlying familial risk for neuropsychiatric 
disorders is critical for identifying potential biomarkers for psychosis. Accordingly, the P3 component has 
demonstrated valuable utility as a biological trait or intermediate phenotype, as reduced P3 amplitudes 
are observed for medication naïve first episode schizophrenia patients along with first-degree family 
members (Kidogami et al., 1991). However, the P3 amplitude does not necessarily distinguish 
schizophrenia patients from other neuropsychiatric disorders, and may instead represent a trait marker for 
more general cognitive symptom pathologies shared among psychiatric disorders (Bestelmeyer et al., 
2009; Johannesen et al., 2012). This is the first study to examine the LPP component in response to task-
irrelevant emotional distractors as a biomarker for schizophrenia. Investigating the electrophysiological 
correlates of affective processing in schizophrenia and first-degree relatives may facilitate the discovery 
of genetic vulnerability markers and biological traits that represent pathophysiological mechanisms and 
cognitive dysfunctions evident in schizophrenia, and aid in the investigation of novel genes of interest 
(Meyer-Lindenberg and Weinberger, 2006).  
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2.2 Electrophysiological Correlates of Aberrant Motivated Attention and Salience Processing in 
Unaffected Relatives of Schizophrenia Patients1 
Introduction  
Schizophrenia (SCZ) is characterized by symptoms spanning psychological, cognitive, and 
behavioral domains. Disturbances in attentional and affective processing are particularly debilitating 
(Keefe and Harvey, 2012), considered core deficits (Nuechterlein et al., 2004), are associated with poor 
functional outcomes (Green et al., 2004; Keefe and Harvey, 2012; Williams et al., 2008), and remain 
difficult symptoms to treat (Erhart et al., 2006). Affective symptoms, including avolition and anhedonia, 
and attentional deficiencies, including impaired vigilance and sustained attention, are not mutually 
exclusive, and collectively rely on frontal and limbic distributed neural networks (Anticevic and Corlett, 
2012). External salience, such as task-relevance, and internal salience, such as emotional or motivational 
aspects of stimuli, compete for frontolimbic engagement to orient attention and facilitate the processing of 
context-appropriate goal-relevant information, while disengaging from salient but task-irrelevant 
distractors. Affective information is particularly salient, and the inability to disengage from emotionally 
salient stimuli may lead to the over-allocation of sustained attention to, and impaired filtering of, irrelevant 
affective stimuli. Similarly, the inability to process external salience may lead to a bias towards affective 
yet task-irrelevant stimuli, further compromising the ability to orient attention to task-relevant stimuli and 
initiate goal-oriented behaviors (Anticevic and Corlett, 2012). Accordingly, the system is left more 
susceptible to interference from salient emotional stimuli. Imbalance in the dynamic interface between 
complementary affective and attention systems may affect numerous aspects of functioning, including 
social engagement, motivation, and overall quality of life (Anticevic and Corlett, 2012). 
There is considerable evidence of aberrant information filtering deficits in SCZ, which potentially 
contribute to aberrant salience detection and an over-evaluation of task-irrelevant information, resulting in 
an inability to stay on task. Reported information filtering deficits in SCZ range from impairments in early 
sensory gating (Patterson et al., 2008), to disruptions in attention orienting (Laurens et al., 2005), to 
                                                            
1This chapter previously appeared as an article in the Clinical EEG and Neuroscience journal. The 
original citation is as follows: Andersen, E.H., Campbell, A.M., Schipul, S.E., Bellion, C.M., Donkers, F.C., 
Evans, A.M., Belger, A., 2016. Electrophysiological Correlates of Aberrant Motivated Attention and 
Salience Processing in Unaffected Relatives of Schizophrenia Patients. Clinical EEG and Neuroscience, 
Vol. 47(1), pp.11-23. Copyright © EEG and Clinical Neuroscience Society (ECNS) 2015. Reprinted by 
permission of SAGE Publications. http://journals.sagepub.com/doi/abs/10.1177/1550059415598063 
28 
 
abnormalities in higher order, goal-directed, and context-driven information processing (Barch and Dowd, 
2010; Heerey and Gold, 2007). Aberrant orienting to task-relevant target information and salience 
detection have also been demonstrated across multiple processing domains in first-degree relatives 
(FDRs), including aberrant working memory (Krabbendam et al., 2001), episodic memory (Toulopoulou et 
al., 2003), executive functioning (Sitskoorn et al., 2004; Staal et al., 2000), and attention (Cornblatt and 
Keilp, 1994), suggesting that deviations in cognitive processing precede psychosis onset and may 
represent vulnerability markers. Elucidating the neurophysiological properties of attentional disturbances 
in patients with SCZ and individuals at familial high risk is critical for advancing our understanding of 
treatment-resistant attentional and affective symptoms, and for identifying novel biomarkers of SCZ to 
facilitate early intervention approaches and treatment strategies. 
The goal of this study was to elucidate the neural correlates underlying the convergence of task-
directed attention and automatic motivated attention to salient emotional distractors in patients with SCZ, 
clinically unaffected FDRs, and healthy control participants. Because of its high temporal resolution, 
electroencephalography (EEG), particularly event-related potentials (ERPs), can differentiate between 
perceptual and cognitive stages of information processing (Hajcak et al., 2010; Luck, 2005; van der Stelt 
and Belger, 2007). As such, ERP measures enable the isolation of distinct attentional and affective 
processing components, including novelty detection and motivated and sustained attention, and can 
inform whether impaired sensory filtering and ineffective salience detection and attribution are associated 
with specific clinical dimensions of SCZ. 
An oddball detection ERP paradigm, combining a target detection task with infrequent emotional 
distractor stimuli, is useful for distinguishing between attentional processing domains, such as directed 
attention to task-relevant events (P3b), novelty detection (P3a), motivated attention to salient stimuli (late 
positive potential [LPP]), and sustained attentional processing (continued late positivity). The P3a 
component is a midline frontal positive waveform peaking at approximately 400 ms following the 
presentation of novel, infrequent stimuli, reflecting attentional capture by salient information (Katayama 
and Polich, 1998; Polich, 2007). Reduced P3a amplitudes have been reported in patients with SCZ, 
reflecting deficits in stimulus orientation, evaluation, discrimination, and salience detection (Turetsky et 
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al., 2009; van der Stelt et al., 2004), and have been related to enhanced positive symptom severity 
(Fisher et al., 2010; Turetsky et al., 2009). A parietally distributed P3b is elicited in response to task-
relevant stimuli, indexing directed attention to “target” events (Falkenstein et al., 1999; Johnson, 1984; 
Katayama and Polich, 1998; Polich, 2007; Snyder and Hillyard, 1976; Squires et al., 1975). Diminished 
P3b amplitudes in auditory (Duncan, 1988; Kidogami et al., 1991; Mathalon, 2000; Roth and Cannon, 
1972) and visual paradigms (van der Stelt et al., 2004) are among the most consistent findings in SCZ 
research (Duncan, 1988; Ford, 1999; Kidogami et al., 1991; Mathalon, 2000; Pritchard, 1986; Roth and 
Cannon, 1972; van der Stelt et al., 2004), and have been associated with abnormalities in directed 
attention, response selection, inhibition, and in aberrant salience attribution to task-relevant stimuli 
(Hajcak et al., 2010; Luck, 2005; Polich, 2007; Squires et al., 1975; van der Stelt and Belger, 2007). 
Reduced P3b (Kidogami et al., 1991; Price et al., 2006; van der Stelt et al., 2005) and auditory P3a 
amplitudes (Jahshan et al., 2012) have also been observed for individuals at clinical and familial high risk, 
suggesting that P3 components may be useful as endophenotypes and clinical state markers, as they can 
track fluctuations in clinical symptom severity (Mathalon et al., 2000). To our knowledge, P3a responses 
elicited in the visual modality have not been studied in individuals at familial high risk. Despite consistent 
findings of reduced P3 amplitudes in SCZ, similar effects have also been found in other neuropsychiatric 
disorders and may represent a trait marker for a central deficit in higher order processing of salient stimuli 
shared across psychopathologies (Bestelmeyer et al., 2009; Johannesen et al., 2012). 
Whereas P3 components have been associated with directed attention and novelty detection, 
motivated and sustained attention to salient stimuli can be indexed by the LPP component. The LPP is 
elicited approximately 400 to 1000 ms post–stimulus onset and may be sustained well past the duration 
of the stimulus (Cuthbert et al., 2000; Hajcak et al., 2010; Hajcak and Olvet, 2008; Horan et al., 2012; 
Matsuda and Nittono, 2015; Schupp et al., 2000). Emotional stimuli evoke larger LPP amplitudes than 
neutral stimuli (Hajcak et al., 2009; Olofsson et al., 2008), suggesting that the LPP indexes sustained 
allocation of attentional resources to, and cognitive elaboration of, emotional, salient events. Recent 
studies have further suggested that early phases of the LPP may be associated with short-latency 
momentary directed attention to affective salient stimuli, whereas a later “sustained” LPP may reflect a 
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prolonged allocation of attention and maintenance of emotional salient information, critical for higher order 
cognitive processing (Hajcak et al., 2010). 
Difficulty disengaging from negative stimuli, impaired sensory filtering, and elevated reactivity to 
irrelevant information may contribute to the relentless heightened negative affect observed in SCZ. 
Negative symptoms, marked by blunted affect, anhedonia, avolition, and enhanced experience of 
aversive emotion, are core clinical symptoms of SCZ, yet most patients express relatively preserved 
aspects of affective processing in experimental settings, including appropriate “in-the-moment” emotional 
responses to affective stimuli (Cohen and Minor, 2008; Horan et al., 2010; Kring and Moran, 2008; 
Strauss and Gold, 2012), and intact LPP valence discrimination between task-irrelevant emotionally 
salient stimuli (Horan et al., 2012) Nevertheless, patients show decreased performance on emotion 
maintenance tasks (for both positive and negative emotion) that were found to be related to deficits in 
motivated behavior (Gard et al., 2011), and deficits in downregulating the LPP response to aversive 
stimuli using cognitive change strategies (Horan et al., 2013; Strauss et al., 2013), suggesting selective 
deficiencies in affective processing. The discrepancy between intact emotional responding in 
experimental settings and clinically relevant negative symptoms in SCZ motivates the investigation of 
neural correlates of salience processing, especially because of its importance in effectively filtering 
irrelevant emotional stimuli to prioritize directed attention and goal-directed, motivational behaviors. This 
is the first study to examine the LPP response in familial risk participants, in addition to patients, and to 
explore its value as a novel biomarker for psychosis. 
We evaluated directed and sustained attentional processing in SCZ and FDR participants relative 
to healthy controls using an oddball detection paradigm, focusing on directed attention to targets (P3b), 
novelty detection of aversive and neutral distractors (P3a), and the motivated (early-LPP) and sustained 
(late-LPP) cognitive elaboration of salient stimuli. We expected both SCZ and FDR to show deficits in the 
P3b responses to targets, as previously demonstrated (Kidogami et al., 1991; Sponheim et al., 2006), 
with FDR participants exhibiting reduced P3b amplitudes at an intermediate level between controls and 
patients. In addition, we predicted that aversive distractors would elicit smaller P3a amplitudes in SCZ 
and FDR relative to controls, reflecting aberrant attention allocation to non-target emotional stimuli (van 
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der Stelt et al., 2004). Consistent with previous studies, we hypothesized that SCZ and FDR participants 
would demonstrate intact affective valence processing, with increased LPP amplitudes for aversive 
compared to neutral stimuli, similar to controls. However, we predicted that the LPP (early, middle, late) 
would be reduced in SCZ and FDR participants relative to controls, indicating aberrant motivated and 
sustained attention to salient stimuli. Furthermore, we investigated the association between the P3a, P3b, 
and LPP amplitudes, symptom severity, and neurocognitive measures to further elucidate the 
electrophysiological correlates of behavioral and cognitive symptoms of SCZ. We expected the P3a, P3b 
and LPP amplitudes to all be inversely related to symptom severity, especially negative and disorganized 
symptom dimensions, and that performance on attentional, executive, and emotional neurocognitive 
assessments would predict target-P3b and aversive early-LPP amplitudes. 
Method 
Participants  
Thirty-one adults diagnosed with SCZ within the past five years (recent-onset), 28 FDRs, and 47 
healthy controls participated in the study (Table 1). Patients were referred by their treating clinicians, or 
recruited along with FDR and control participants from the community. Patients with SCZ met the 
Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) criteria for schizophrenia (n 
= 18), schizoaffective (n = 12), or schizophreniform (n = 1) disorder and had stable symptoms. The 
majority of patients were medicated with first-generation (n = 22) or second-generation (n = 1) 
antipsychotics; however, 8 participants were not medicated due to their recent diagnosis. FDR 
participants had a first-degree relative with a diagnosis of a schizophrenia-spectrum illness, no past or 
current Axis I disorders, and were not currently taking antipsychotic medications. Three FDR participants 
were taking antidepressants. Control participants had no history of a DSM-IV Axis I diagnosis and no first-
degree relatives diagnosed with schizophrenia-spectrum illness. All participants spoke English, were 18 
to 48 years old, had normal or corrected vision, and no history of neurological disorders. Participants 
were allowed to smoke and consume caffeine up until 40 minutes prior to the experiment in accordance 
with their habitual smoking and drinking patterns. Participants provided informed consent in accordance 
with the University of North Carolina at Chapel Hill Institutional Review Board. 
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Procedures 
The testing session included clinical screening, neurocognitive testing, and an EEG session. 
Clinical screening included the Scale of Prodromal Symptoms (SOPS) (McGlashan et al., 2001; Miller et 
al., 1999), the Positive and Negative Syndrome Scale (PANSS) (Kay et al., 1987), and the Premorbid 
Adjustment Scale (Cannon-Spoor et al., 1982), among others. Participants completed a neurocognitive 
test battery, including the Facial Emotion Identification Test (FEIT) (Kerr and Neale, 1993), Baron-Cohen 
“Reading the Mind in the Eyes” Test–Revised (BCAET) (Baron-Cohen et al., 2001), Continuous 
Performance Test-Identical Pairs (CPT-IP) (Cornblatt et al., 1989), and Delis-Kaplan Executive Function 
System–Color-Word Interference Test (DKEFS-CWIT) (Lippa and Davis, 2010). IQ was estimated using 
the North American Adult Reading Test (NAART) (Uttl, 2002). 
ERP Emotional Oddball Task 
EEG was recorded while participants performed a forced-choice oddball detection task with 
infrequent animal target images (n = 70; 6.3%) embedded among frequent standard scrambled images (n 
= 900; 81.1%), and infrequent novel neutral (n = 70; 6.3%) and aversive (n = 70; 6.3%) distractor images. 
Colored images were selected from the International Affective Picture System (IAPS) database (Lang et 
al., 2008). Average arousal and valence ratings for the neutral stimuli (common household objects, 
activities) were 3.28 (SD = 2.01) and 5.24 (SD = 1.39), respectively, aversive stimuli depicting scenes of 
human violence, mutilation, and disease were (Marousal = 6.44, SD = 2.17) and (Mvalence = 2.32, SD = 1.53), 
and nonthreatening target animal images were (Marousal = 4.21, SD = 2.2) and (Mvalence = 7.01, SD = 1.6). 
The task consisted of 10 blocks, three minutes each. Stimuli were pseudorandomized to ensure that the 
novel targets, aversive, and neutral images were followed by at least two standard images. Stimuli were 
presented for 500 ms, with variable interstimulus intervals between 1300 and 1700 ms during which a 
fixation cross appeared. Participants responded with their right middle finger for targets and their index 
finger for all other stimulus types. 
EEG Recording and Processing 
EEG was continuously recorded using a NeuroScan 4.3 SynAmps2 amplifier and a 32-electrode 
ECI Electro cap. AFz served as ground and right mastoid as reference. Vertical and horizontal 
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electrooculogram (VEOG/HEOG) were measured using bipolar recordings. Data were sampled at 500 Hz 
in AC acquisition mode, bandpass filtered online between 0.15 and 70Hz, with a 60-Hz notch filter, and 
impedances were maintained below 10 kohm. Analyses were conducted with SCAN 4.4 Edit Software 
(Compumedics Neuroscan, Charlotte, NC.). Ocular artifacts, including eye movements and blinks, were 
corrected with an algorithm implemented in Neuroscan (Semlitsch, 1986). Major artifacts were manually 
rejected, and data corresponding with incorrect behavioral responses were removed. Epochs of 200-ms 
prestimulus to 1000-ms poststimulus were segmented, artifact rejected (±100 µV at any electrode), 
baseline corrected (200ms), averaged, and 15-Hz low-pass filtered offline for each stimulus type. 
ERP Data Analysis 
The P3 amplitude was defined as the average amplitude within the 350 to 500 ms window post–
stimulus onset; target-P3b was analyzed from the mid-parietal Pz electrode (Comerchero and Polich, 
1999; Horan et al., 2012; Polich, 2007; Turetsky et al., 2009), and P3a was analyzed from the mid-frontal 
Fz electrode (Comerchero and Polich, 1999; Jahshan et al., 2012; Polich, 2007), consistent with previous 
studies. To encapsulate the early and late LPP peaks observed in the grand average waveforms for novel 
stimuli, the LPP was analyzed in 3 distinct windows (early, 350-500 ms; middle, 500-650 ms; late, 650-
800 ms) from Pz electrode (Hajcak et al., 2010). There were no differences between groups for the 
number of accepted trials for standard (M = 582.0, SD = 84.1), aversive (M = 55.7, SD = 10.7), neutral (M 
= 59.0, SD = 9.9) and target stimuli (M = 50.5, SD = 10.3). 
Statistical Analyses 
Statistical analyses were performed using PASW Statistical Software, version 18.0 (SPSS Inc, 
2009). Demographic and clinical data were analyzed using analyses of variance (ANOVAs) for continuous 
variables and chi-square tests for categorical variables. Behavioral and EEG results were analyzed using 
repeated-measures (rm) ANOVAs, with age and sex entered as covariates. A Group (SCZ, FDR, control) 
 Stimulus (standard, neutral, target, aversive) rm-ANOVA was performed separately for reaction time 
(RT) and accuracy. P3a was assessed using a Group  Stimulus (aversive, neutral, standard) rm-
ANOVA, and the target-P3b was analyzed using a Group  Stimulus (target, standard) rm-ANOVA. LPP 
was evaluated with a Group  Valence (aversive, neutral)  Window (early, middle, late) rm-ANOVA. Post 
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hoc pairwise comparisons were Bonferroni corrected for multiple comparisons and Greenhouse-Geisser 
epsilon corrections were used when the sphericity assumption was violated. 
The relationship between SOPS (positive, negative, and disorganization) scores for FDR and 
SCZ, and neurocognitive measures of executive functioning (scaled DKEFS-CWIT inhibition/switching 
score), attentional (d-prime for a 3-digit CPT-IP test) and emotional (BCAET and FEIT) processing for all 
participants, were correlated with target-P3b, aversive and neutral P3a, and early- and late-LPP 
components using Spearman’s rank correlation analysis. 
Results 
Demographics and Clinical Assessments 
Groups differed on age, F(2, 103) = 5.39, P < 0.05; sex, χ(2) = 25.73, P < 0.001; and education, 
F(2, 102) = 4.27, P < 0.05, with a younger, predominately male patient group and an older, female-
dominated FDR group. Age and sex were therefore entered as covariates in subsequent analyses. 
Patients exhibited a lower educational level than controls (P < 0.05). SCZ patients differed from controls 
on IQ and FEIT measures (P < 0.05), and differed from controls and FDR participants on BCAET (P < 
0.05), DKEFS (P < 0.05), CPT-IP (P < 0.05), and all SOPS scores (P < 0.001). FDR participants were 
equivalent to controls on all SOPS and neurocognitive assessments (P > 0.05 for all; Table 2.1).  
Behavioral Results 
There was a main effect of Stimulus for both RT, F(3, 300) = 9.38, P < 0.001, ηp2 = 0.09, and 
accuracy, F(1.62, 162.23) = 11.36, P < 0.001, ηp2 = 0.10, such that responses to standard images were 
faster and more accurate for all groups, and participants were slower and less accurate for target stimuli. 
A Stimulus  Group interaction, F(6, 300) = 57.99, P < 0.001, ηp2 = 0.54, was found for RT, revealing that 
while FDRs and controls had similar RTs, patients with SCZ demonstrated slower RTs for neutral stimuli 
than controls (t = 4.16, P < 0.001) and FDR participants (t = 3.49, P < 0.05), and faster responses for 
aversive stimuli relative to control (t = 8.28, P < 0.001) and FDR participants (t = 6.56, P < 0.001). A 
Group effect, F(2, 100) = 5.55, P < 0.05, ηp2 = 0.10, for accuracy indicated that SCZ patients had lower 
accuracy for neutral (t = 2.99, P < 0.05) and aversive stimuli (t = 2.53, P < 0.05) relative to controls. RT 
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and accuracy for target stimuli did not differ between groups (P > 0.05 for all). No additional effects or 
interactions were found (Table 2.2).  
ERP Results From Oddball Paradigm 
Target Detection–P3b. A Group main effect, F(2, 101) = 17.83, P < 0.001, ηp2 = 0.26, was 
observed for target-P3b, indicating that controls demonstrated significantly greater target-P3b responses 
compared with FDR (t = 2.47, P < 0.05) and SCZ (t = 5.67, P < 0.001) participants. A significant main 
effect of Stimulus, F(1, 101) = 18.32, P < 0.001, ηp2 = 0.15, confirmed that the response to target stimuli 
was greater than that for standard stimuli for control (t = 15.67, P < 0.001), FDR (t = 8.43, P < 0.001), and 
patients with SCZ (t = 6.31, P < 0.001). Additionally, a Group  Stimulus interaction, F(2, 101) = 10.24, P 
< 0.001, ηp2 = 0.17, revealed that the difference between responses to target and standard stimuli was 
less for patients with SCZ relative to controls and FDR participants (Table 2.2; Figure 2.1). 
Novelty Processing–P3a. No significant main effects or interactions were found for novel-P3a (P 
> 0.64; F < 0.39 for all). To verify that the amplitude responses for novel stimuli were greater than 
responses for standard stimuli, as expected for P3a, planned pairwise comparisons were performed and 
indicated that all groups demonstrated increased P3a amplitudes for aversive (CON, t = 4.93, P < 0.001; 
FDR, t = 2.78, P < 0.05; SCZ, t = 3.59, P < 0.05) and neutral (CON, t = 3.75, P < 0.05; FDR, t = 2.68, P < 
0.05; SCZ, t = 2.79, P < 0.05) stimuli compared with standard stimuli (Table 2.2; Figure 2.1). The P3a was 
initially analyzed from Fz, FCz, and Cz electrodes to account for the understood frontocentral distribution 
of the component. While there was a group effect at Cz, with patients demonstrating reduced P3a 
amplitudes relative to controls, this analysis is not included because it is possible that the enhanced 
amplitude at Cz is attributable or simply carried over from the early-LPP response from Pz. P3a is 
typically assessed from frontal electrodes, as it is understood to underlie a predominately frontal process 
(Daffner et al., 2000; Friedman and Simpson, 1994; Knight, 1997). 
Motivated Attention and Salience Processing–Late Positive Potential. A significant Group effect, 
F(2, 101) = 12.38, P < 0.001, ηp2 = 0.20, demonstrated that SCZ patients exhibited reduced LPP 
responses overall compared with control (t = 4.77, P < 0.001) and FDR (t = 3.94, P < 0.001) participants. 
No main effects of Window or Valence were found. A Window  Group interaction, F(3.02, 152.27) = 7.34, 
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P < 0.001, ηp2 = 0.13, indicated that patients had reduced LPP amplitudes in the early and middle 
windows compared with controls (early, t = 5.53, P < 0.001; middle, t = 2.81, P < 0.05) and all three 
windows with FDR (early, t = 2.68, P < 0.05; middle, t = 2.72, P < 0.05; late, t = 3.40, P < 0.05), and that 
FDR participants demonstrated greater LPP amplitudes compared with control participants during the late 
LPP window (t = 2.73, P < 0.05). A significant Valence  Window  Group interaction, F(3.74, 188.81) = 
3.00, P < 0.05, ηp2 = 0.06, suggested that FDR participants uniquely exhibited a greater positivity for 
aversive and neutral stimuli relative to control (aversive, t = 2.55, P < 0.05; neutral, t = 2.54, P < 0.05) and 
SCZ (aversive, t = 3.00, P < 0.05; neutral, t = 3.37, P < 0.05) participants during the late window only. 
During the early window, controls demonstrated greater LPP amplitudes in response to aversive stimuli 
relative to FDR (t = 2.50, P < 0.05) and SCZ participants (t = 5.46, P < 0.001), and greater LPP 
amplitudes for neutral stimuli compared with SCZ patients (t = 5.13, P < 0.001). FDR participants 
exhibited greater LPP responses during the early window for neutral stimuli relative to SCZ patients (t = 
2.93, P < 0.05). Unlike controls and SCZ patients, FDR participants did not show valence discrimination 
during the early window, as the LPP response to aversive and neutral stimuli did not differ (t = 1.63, P > 
0.05). During the middle LPP window, SCZ patients demonstrated reduced LPP responses for aversive 
and neutral stimuli compared with controls (aversive, t = 2.75, P < 0.05; neutral, t = 2.52, P < 0.05) and 
FDR participants (aversive, t = 2.45, P < 0.05; neutral, t = 2.69, P < 0.05) (Table 2.2; Figure 2.2). 
Relationship Between Clinical and Neurocognitive Assessments and ERP Components 
Spearman’s rank correlations revealed that reduced target-P3b and aversive early-LPP 
amplitudes were associated with increased positive (P3b, rs = 0.27, P = 0.04; early-LPP, rs = 0.35, P = 
0.01) and negative symptom severity (P3b, rs = 0.29, P = 0.03; early-LPP, rs = 0.33, P = 0.01), reduced 
aversive late-LPP amplitudes were related to increased negative symptoms (rs = 0.39, P = 0.00), and 
reduced aversive P3a amplitudes (rs = 0.28, P = 0.03) were related to increased positive symptoms, 
across FDR and SCZ participants. Additionally, greater target-P3b and aversive early-LPP amplitudes 
were associated with increased performances on executive functioning (DKEFS-CWIT; P3b, rs = 0.30, P 
= 0.00; early-LPP, rs = 0.28, P = 0.01), attentional processing (CPT-IP; P3b, rs = 0.29, P = 0.00; early-
LPP, rs = 0.32, P = 0.00), and affective processing (BCAET; P3b, rs = 0.27, P = 0.01; early-LPP, rs = 0.31, 
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P = 0.00) neurocognitive tasks, and greater aversive late-LPP and neutral P3a amplitudes were 
correlated with increased attentional (late-LPP, rs = 0.27, P = 0.01; P3a, rs = 0.22, P = 0.03) and affective 
processing (late-LPP, rs = 0.26, P = 0.01; P3a, rs = 0.25, P = 0.01) performances, across all participants. 
Refer to Supplementary Table 1 (available at http://eeg.sagepub.com/content/by/supplemental-data) for 
additional information (selected correlations presented in Figure 2.3). 
Discussion 
Results from the present study suggest that deficits in multiple stages of information processing 
map onto specific disruptions in attention and affective salience detection in SCZ patients and FDR 
individuals. During an early stage of attention orienting and novelty detection, both SCZ and FDR 
participants showed intact novelty detection (P3a), yet exhibited deviations in neural correlates of directed 
attention to task-relevant stimuli (target-P3b), and motivated attention to salient distractors (early-LPP). 
Diminished P3b amplitudes for target stimuli and aberrant LPP responses for salient distractors may 
reflect disruptions in attentional tuning in SCZ and FDR participants, and an overall reduction in signal-to-
noise discrimination. Impaired sensory filtering and salience processing may interfere with cognitive 
processes essential for social interactions and goal-directed behaviors. In this study, the neural correlates 
of attentional processing for FDR participants were found to be intermediate to the SCZ patients and 
controls, suggesting that P3b and early-LPP components may represent neurophysiological markers for 
psychosis, and may potentially facilitate the identification of vulnerable individuals in younger populations. 
In contrast to the earlier directed attention responses, FDR participants exhibited a unique 
enhancement of the late-LPP amplitude, suggesting sustained motivated attention to emotional (albeit 
task-irrelevant) information. While the neurocognitive and behavioral significance of this enhanced 
processing of task-irrelevant affective information remains unclear, it may reflect a compensatory 
mechanism that engages “alternate” salience systems to compensate for loss of signal at earlier stages of 
processing. Conversely, the distinct augmentation of the late positivity could reflect maintenance of the 
salient representation for later and higher order cognitive processes, therefore enabling FDR participants 
to achieve a behavioral performance comparable to controls. Elevated sustained processing of salient 
stimuli may promote superior allocation of attention, thereby minimizing symptom manifestation in 
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vulnerable individuals. Alternatively, enhanced sustained motivated attention may reflect an inability to 
switch off erroneous salience signals. Future research should examine the utility of the LPP component in 
the detection and prediction of psychopathology, as a distinct risk marker for aberrant salience and 
attentional processing, and its potential value in distinguishing between psychotic disorders. 
The electrophysiological abnormalities underlying attentional processing in SCZ and FDR 
participants may represent disruptions in frontolimbic circuitry, critical for maintaining an effective 
interaction between frontal executive and limbic affective processing networks. Dichter et al (2010) 
reported a disrupted balance between a dorsal executive network and a ventral affective system 
responsible for attention and emotion regulation in patients with SCZ, resulting in the disproportionate 
recruitment of limbic regions. The exaggerated limbic response may promote greater affective 
interference (Anticevic and Corlett, 2012; Dichter et al., 2010; Fichtenholtz et al., 2004) and result in 
attentional disturbances manifested in the reduced directed attention ERP responses to task-relevant 
target events and novel distractors. Future research could employ parallel functional magnetic resonance 
imaging and EEG to elucidate atypical circuitry underlying discrepancies in LPP amplitudes between 
groups. 
SCZ participants demonstrated intact novelty detection, indexed by the P3a amplitude, and 
valence discrimination, as LPP amplitudes were larger for aversive than neutral stimuli. In contrast to 
previous studies reporting reduced P3a amplitudes in patients with SCZ (Turetsky et al., 2009; van der 
Stelt et al., 2004), the present study found novelty orientation undisturbed in patients and relatives. 
Inconsistent results could be attributed to differences in task design (content of novel stimuli), sensory 
modality, or discrepancies in the electrode(s) (Fz, Pz) used in the analysis. While P3a is understood to be 
a frontocentral component, it has also been found to be maximal at parietal locations in novel oddball 
variants (van der Stelt et al., 2004), muddling the distinction between early-LPP and P3a. Intact novelty 
detection and valence discrimination observed in the present study support previous research suggesting 
that SCZ patients’ emotion-dependent attention was relatively undisturbed (Horan et al., 2012). Despite 
intact novelty detection, FDR participants uniquely exhibited aberrant salience processing, indicated by 
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the indistinguishable early-LPP response for neutral and aversive stimuli, additional evidence for atypical 
salience processing in FDR. 
While patients demonstrated intact behavioral accuracy and reaction times for target stimuli, they 
exhibited longer reaction times for neutral stimuli, and shorter reaction times for aversive stimuli. This 
finding provides evidence in support of aberrant salience processing in psychosis, whereby patients 
attribute inappropriate salience and motivational significance to irrelevant stimuli, potentially 
accompanying dysregulated dopamine release (Kapur, 2003). FDR participants did not differ from 
controls on behavioral performance, and appropriately exhibited slower responses to emotional stimuli, 
potentially reflecting deeper processing of these events, along with control participants. SCZ patients 
additionally demonstrated reduced accuracy for aversive and neutral images, indicating that SCZ patients 
are biased toward target responses. In contrast to prior evidence of intact overt, “in-the-moment” 
emotional processing in SCZ, these findings suggest atypical processing of salient, emotional distractors 
and disruptions in frontolimbic engagement (Laurens et al., 2005; Liu et al., 2012). 
Severity of negative, positive, and disorganized symptoms was associated with reduced neutral 
and aversive early-LPP amplitudes across FDR and SCZ participants, suggesting that the early-LPP may 
offer a method for tracking fluctuations in clinical state. Deficits in attention orienting, reflected in reduced 
auditory P3a amplitudes, have been reported to be associated with increased negative symptoms in 
individuals at clinical risk for psychosis (Jahshan et al., 2012). While there was no relationship between 
P3a and negative symptoms in this study, severity of negative symptoms was found to be related to 
reduced early-LPP and target-P3b amplitudes, also suggestive of potential impairments in attentional 
processing promoting negative symptom pathology. More profound deficits in P3b amplitude have also 
been reported in patients with more severe negative symptoms (Liu et al., 2004), further supporting a 
critical role for P3b in targeting treatments for especially debilitating negative symptoms, and for its utility 
as a biomarker for neuropsychopathology. Furthermore, executive functioning, attentional processing and 
the ability to identify emotional facial expressions were associated with higher target-P3b and early-LPP 
amplitudes, suggesting that cognitive behavioral therapy or other intervention techniques may be effective 
in addressing affective and attentional processing impairments, and subsequently enhancing P3 and LPP 
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amplitudes in affected individuals. Additionally, superior attentional processing, reflected in the CPT 
sensitivity index, was related to novelty detection (P3a) and salience processing (late-LPP), indicating 
that novelty orienting, sustained attention to salience and maintaining motivational significance may be 
associated with improved performance on attentional tasks. This finding provides additional support for 
the LPP underlying a potential compensatory mechanism in FDR participants. 
Although FDR participants did not demonstrate observable affective or attentional deficiencies, as 
measured by clinical assessments and neurocognitive testing, they shared deviant neurophysiological 
correlates of directed (target-P3b) and motivated attention (early-LPP) with SCZ patients. While SCZ and 
FDR participants were able to detect novel distractor stimuli appropriately, they demonstrated aberrant 
motivated attention, possibly attributable to disturbances in sensory filtering or early stages of attention 
orienting, which contributed to a reduced distinction between the signal response to task stimuli and 
background EEG “noise.” Furthermore, FDR participants displayed atypical sustained salience 
processing reflected in the elevated late-LPP response for aversive and neutral stimuli, indicating reduced 
network efficiency relative to healthy controls. To perform equivalently to controls behaviorally, it appears 
that FDR participants prioritize salience processing by engaging a compensatory neural mechanism to 
overcome deficits in cognitive functioning. Without the compensatory recruitment of neural circuitry and 
resulting elevation of late positivity, SCZ patients may be unable to perform at the same level as control 
and FDR participants. These findings suggest that first-degree relatives of SCZ patients have aberrant 
attentional neural processing (P3b and LPP), which does not lead to clinical symptoms, perhaps because 
of compensatory neural processing, reflected in the elevated late positivity. These findings may have 
implications for targeting salience processing to improve cognitive deficits and clinical symptom severity, 
as they suggest that the LPP component may be used as a neurophysiological marker for assessing 
directed and motivated attention deficits in individuals at risk for psychosis. 
There are several limitations to the current study. Valence and arousal ratings of the aversive 
stimuli from this set of participants were not available and would have been necessary to compare the 
experience of unpleasant stimuli between patients with SCZ, FDR participants, and controls. While limited 
medication exposure could interfere with accurate interpretation of patients’ results (Coburn et al., 1998; 
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Gonul et al., 2003), we purposely recruited recently diagnosed patients to minimize chronic 
pharmacological effects. Even though age and sex were entered as covariates in the analyses, it should 
be noted that the FDR group was largely made up of older, female individuals and it is known that 
females respond differently to emotional stimuli (Stevens and Hamann, 2012; Whittle et al., 2011). 
Balanced experimental groups, or studies restricted to male participants, would be necessary to elaborate 
on the sex contributions to the current results. The study was intended to examine familial high risk, and 
not promote predictions for disease onset; however, future studies assessing adolescent FDRs with 
prodromal symptoms would offer valuable insight for the use of this paradigm in assessing risk for SCZ. 
The goal of the current study was to investigate directed and sustained motivated attention to 
salience in SCZ patients and FDR participants to determine whether deterioration of the complementary 
affective and attention systems potentially underlies abnormalities in cognitive and behavioral functioning, 
and negative symptom pathology. This is the first study, to our knowledge, to explore the 
neurophysiological correlates of early and late motivated attention and salience processing in FDR 
individuals, and provides promising evidence for a compensatory neural mechanism, which allows FDR 
participants to perform behaviorally equivalent to healthy controls. Results suggest that early and late 
LPP responses may reflect novel vulnerability markers of aberrant attentional processes in individuals at 
risk for psychosis. 
 
2.3 Future Directions 
Preliminary analyses evaluating the oscillatory activity underlying directed and sustained 
motivated attention to salient stimuli during the emotional oddball paradigm found additional evidence for 
a compensatory mechanism in FDR and aberrant salient processing in SCZ patients. Consistent with the 
elevated LPP amplitude, FDR participants (N = 26) additionally exhibited a unique enhancement of beta 
oscillatory activity (16-30 Hz) in response to aversive stimuli relative to a control group matched on age 
and sex [t=2.2, p<0.05)] (Figure 2.4). Additionally, SCZ patients (N = 30) demonstrated reduced evoked 
power (EP) [(t=2.4, p<0.05] and intertrial (phase) coherence (ITC) [t=3.1, p<0.05] in the theta frequency 
range (4-8 Hz) in response to aversive stimuli. Disrupted theta activity potentially reflects impaired fronto-
limbic connectivity involved in the evaluation of emotional stimuli (Aftanas et al., 2001; Ertl et al., 2013; 
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Lesting et al., 2011), and is consistent with previous research from our lab demonstrating reduced theta in 
adolescents at high-risk for SCZ (Donkers et al., 2011). Furthermore, deficits in delta EP [SCZ: t=2.6, 
p<0.05; FDR: t=2.4, p<0.05] and ITC [SCZ: t=2.6, p<0.05; FDR: t=2.4, p<0.05] for SCZ and FDR 
participants may underlie impairments in the suppression of affective networks responsible for adaptive 
gating of emotionally salient distractor stimuli. Controls demonstrated increased delta EP for targets 
compared with aversive stimuli, suggesting that delta may be involved in the inhibition of affective 
networks during target processing to allow for appropriate task-relevant electrophysiological responses. In 
contrast, the delta response did not distinguish stimulus type in SCZ patients and FDR participants 
(Andersen et al, in preparation, Figure 2.5).  
2.4 Significance 
 Investigating the neurophysiological correlates of motivated attention and salience processing in 
SCZ patients and first-degree relatives advanced the understanding of familial risk, and identified 
potential biomarkers for core symptom domains of schizophrenia. The unique affective response pattern 
found for FDR participants may represent a compensatory engagement of affective circuitry that allows 
the clinically unaffected FDR individuals to achieve a behavioral performance equivalent to controls. 
Disruptions in P3 and LPP responses for aversive stimuli may serve as neurophysiological markers of 
SCZ, and aid in the detection and prediction of psychopathology. Despite patients’ intact valence 
discrimination and cognitive elaboration of emotional stimuli in a simple oddball paradigm, it is unclear 
whether SCZ patients will be able to utilize a cognitive framing strategy to alleviate the 
electrophysiological response to aversive stimuli and maintain the capacity for valence discrimination 
following a stress manipulation.  
These preliminary results suggest that SCZ patients and FDR participants demonstrate aberrant 
neural correlates of attentional processing, and FDR participants additionally exhibit a unique deviation in 
sustained affective processing. The next experiment described in Chapter 3 further elucidates the neural 
mechanisms governing affective processing in SCZ, and characterizes the mechanisms by which 
affective regulation is influenced by psychosocial stress, both reliant on the appropriate engagement of 
fronto-limbic circuitry.  
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Chapter 2.2 Tables 
Table 2.1. Demographics 
  Controls (n = 47)  FDR (n = 28)  SCZ (n = 31)  Statistic 
Age in years, mean (SD)  26.8 (7.0)  30.7 (8.5)  24.8 (5.2)  F(2, 105) = 5.4* 
Sex (% male)  53.2  17.9  83.9  2 (2, 105) = 25.7** 
Ethnicity (%)         
  White/Caucasian  70.2  57.1  58.1   
  African American  29.8  25  35.5   
  Asian  0  3.6  3.2   
  Multiple  0  10.7  0   
  Other  0  3.6  3.2   
Education, mean (SD)a  3.2 (1.4)  3.2 (1.8)  4.2 (1.6)  F(2, 104) = 4.3* 
Average SES, mean (SD)b  15.2 (2.2)  15.0 (2.3)  15.1 (2.4)  F(2, 103) = 0.07 
Duration of illness, mean (SD)      2.3 (1.8)   
SOPS, mean (SD)         
  Total positive  1.0 (1.6)  1.7 (2.0)  11.0(6.0)  F(2, 104) = 81.3** 
  Total negative  0.8 (1.3)  1.9 (2.5)  14.1 (7.2)  F(2,104) = 103.3** 
  Total disorganized  0.3 (0.7)  1.0 (1.6)  5.2 (4.3)  F(2,104) = 37.1** 
  Total general  0.7 (1.2)  2.3 (2.5)  5.4 (4.4)  F(2,104) = 26.4** 
Neurocognitive measures, mean 
(SD) 
       
  Estimated IQc  113.6 (7.0)  112.2 (8.6)  107.9 (10.6)  F(2, 100) = 4.0* 
  D‐KEFS:IS  11.1 (2.6)  11.1 (2.3)  8.6 (3.5)  F(2, 97) = 8.5** 
  CPT‐IP:d’  3.7 (.7)  3.7(.7)  3.0 (.9)  F(2,94) = 8.0* 
  FEIT  13.0 (2.9)  13.0 (2.4)  11.5 (2.3)  F(2, 99) = 3.5* 
  BCAET  27.3 (4.0)  27.2 (3.8)  24.4 (4.1)  F(2, 99) = 5.4* 
 
Abbreviations: SCZ, patients with schizophrenia; FDR, first-degree relatives; SES, socioeconomic status; 
SOPS, Scale of Prodromal Symptoms; FEIT, Facial Emotion Identification Test; D-KEFS:IS, Delis-Kaplan 
Executive Function System–Color-Word Interference Test–inhibition/switching scaled score; CPT-IP:d, 
Continuous Performance Test–Identical Pairs Sensitivity Index; BCAET, Baron-Cohen “Reading the Mind 
in the Eyes” Test. 
a1 = graduate training, 2 = college graduate, 3 = at least 1 year of college, 4 = high school graduate/GED, 
5 = did not finish high school, 6 = elementary school, 7 = less than 8 years of school. 
bAverage years of parental education serves as a proxy for SES. 
cIQ estimated using North American Adult Reading Test (NAART). 
*P < .05. **P < .001. 
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Table 2.2. Results for Oddball Detection Paradigm 
Latency (ms) 
Controls  
(n = 47) 
FDR  
(n = 28) 
SCZ  
(n = 31) 
Post Hoc t values 
CON vs FDR  SCZ vs FDR  CON vs SCZ
Behavioral results             
  Standard  342.7 (52.5)  356.1 (83.4) 367.1 (61.8) 0.5  1.0  1.8 
  Neutral  502.5 (72.6)  511.9 (63.5) 560.5 (68.1) 0.2  3.5*  4.2** 
  Aversive  536.1 (70.3)  547.7 (65.7) 383.0 (78.7) 0.0  6.6**  8.3** 
  Target  571.1 (88.5)  593.4 (63.6) 562.2 (69.0) 0.2  0.8  0.7 
  F values           
Stimulus (df = 3, 300)  9.4**           
Group (df = 2, 100)  0.2           
Stimulus  Group (df = 6, 300)  58**           
Accuracy (%) 
  Standard  97.9 (2.5)  96.3 (8.1)  94.6 (5.1)  2.2  0.4  1.9 
  Neutral  95.3 (4.3)  95.2 (7.7)  87.9 (13.1)  0.8  1.7  2.9* 
  Aversive  92.4 (4.4)  91.2 (9.4)  84.5 (16.2)  1.3  0.9  2.5* 
  Target  81.1 (13.0)  83.0 (10.4)  72.2 (13.8)  0.4  1.4  2.2 
  F values           
Stimulus (df = 1.6, 162.2)  11.4**           
Group (df = 2,100)  5.6*           
Stimulus  Group (df = 3.2, 162.2)  0.8           
ERP results 
Target P3b amplitude (Pz) 
  Target  14.3 (4.7)  11.4 (4.7)  8.2 (3.6)  2.5*  2.4  5.7** 
  Standard  3.5 (1.6)  3.5 (2.6)  2.2 (2.0)  0.6  1.3  2.3 
  F values           
Stimulus (df = 1, 101)  18.3**           
Group (df = 2, 101)  17.8**           
Stimulus  Group (df = 2, 101)  10.2**           
Average P3a amplitude (Fz) 
  Aversive  3.6 (2.2)  4.2 (2.5)  3.4 (2.8)  0.2  0.1  0.4 
  Neutral  3.1 (2.0)  3.9 (2.4)  3.1 (2.6)  0.8  0.3  0.5 
  Standard  1.9 (1.1)  2.4 (1.4)  2.1 (1.7)  1.2  0.4  0.8 
  F values           
Valence (df = 1.7, 168.4)  0.4           
Group (df = 2, 101)  0.4           
Valence  Group (df = 3.3, 168.4)  0.1           
Late positive potential (Pz) 
Aversive (350‐500 ms)  11.1 (4.4)  8.7 (3.7)  6.0 (3.1)  2.5*  2.2  5.5** 
Neutral (350‐500 ms)  9.2 (3.7)  7.7 (4.0)  5.0 (2.6)  1.4  2.9*  5.1** 
Aversive (500‐650 ms)  7.1 (3.7)  7.4 (3.4)  5.0 (3.3)  0.3  2.5*  2.8* 
Neutral (500‐650 ms)  5.5 (2.7)  6.0 (2.9)  3.9 (2.9)  0.8  2.7*  2.5* 
Aversive (650‐800 ms)  4.6 (2.8)  6.6 (3.4)  3.8 (3.0)  2.6*  3.0*  1.1 
Neutral (650‐800 ms)  3.3 (1.8)  4.6 (2.7)  2.5 (2.4)  2.5*  3.4*  1.6 
  F values           
Valence (df = 1, 101)  0.0           
Window (df = 1.5, 152.3)  2.3           
Group (df = 2, 101)  12.4**           
Valence  Group (df = 2, 101)  0.7           
Valence  Window (df = 1.9, 188.8)  0.1           
Window  Group (df = 3.0, 152.3)  7.4**           
Valence  Window  Group (df = 3.7, 188.8)  3.0*           
Abbreviations: CON, controls; SCZ, patients with schizophrenia; FDR, first-degree relatives; ERP, event-
related potential. 
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aMean amplitudes (µV) recorded from Pz. Standard deviations are presented in parentheses. Controls 
missing 1 participant’s behavioral data (n = 46). Post hoc comparisons are Bonferroni corrected for 
multiple comparisons. Sex and age were entered as covariates. 
*P < .05. **P < .001. 
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Chapter 2.2 Figures 
Figure 2.1. Novelty Detection of Novel Distractor Stimuli and Directed Attention to Targets 
 
 
Grand average waveforms for neutral, aversive, and target stimuli recorded from Fz, Cz, and Pz 
electrodes for SCZ, FDR, and controls. Gray boxes indicate the analysis window (350-500 ms). P3a was 
analyzed from Fz, early-LPP and P3b were analyzed from Pz. SCZ, patients with schizophrenia; FDR, 
first-degree relatives; LPP, late positive potential. 
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Figure 2.2. Late Positive Potential (LPP) Underlying Motivated Attention and Salience Processing 
 
 
The LPP grand average waveforms elicited from Pz in response to neutral and aversive stimuli for SCZ, 
FDR, and controls. Gray boxes indicate the early (350-500 ms), middle (500-650 ms), and late (650-800 
ms) analysis windows. SCZ, patients with schizophrenia; FDR, first-degree relatives. 
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Figure 2.3. Relationship between SOPS, Neurocognitive Assessments, and Oddball ERP 
Amplitudes 
 
 
A. More severe negative symptoms are related to reduced target-P3b. B. More severe positive symptoms 
are associated with reduced aversive early-LPP. C. Superior attentional processing is related to greater 
target-P3b. D. Increased aptitude for facial emotion identification is associated with greater aversive 
early-LPP. ERP, event-related potential; LPP, late positive potential; SOPS, Scale of Prodromal 
Symptoms; CWIT, Color-Word Interference Test; BCAET, Baron-Cohen “Reading the Mind in the Eyes” 
Test. 
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Chapter 2.3 Figures 
Figure 2.4. Enhanced Beta Activity in FDR in Response to Aversive Stimuli  
 
 
 
 
 
 
 
Evoked power in beta frequency range (16-30 Hz) from mid-parietal electrode (Pz) during the LPP 
window (550-800 ms) for first-degree relatives and healthy controls. 
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Figure 2.5. Disrupted Neural Oscillatory Activity in SCZ and FDR 
 
A. Delta evoked power for target vs. aversive stimuli. B. Theoretical model depicting impaired delta 
inhibition in response to target animal stimuli for SCZ and FDR promoting affective interference. 
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CHAPTER 3: STRESS EFFECTS ON EEG CORRELATES OF AFFECTIVE PROCESSING 
3.1 Context 
 SCZ patients and first-degree relatives demonstrated aberrant electrophysiological correlates of 
affective processing, with reduced ERP indices of motivated attention and salience processing. First-
degree relatives additionally revealed exaggerated LPP and beta oscillatory responses for aversive 
stimuli, possibly indicating a compensatory engagement of neural circuitry. To advance the understanding 
of the electrophysiological correlates of aberrant affective and salience processing in SCZ patients, the 
next experiment used an emotional oddball framing task to probe the integrity of fronto-limbic circuitry, 
and then challenged the circuitry with a psychosocial stressor to see how well it adapted to and recovered 
from stress exposure. The study design combined electrophysiological measures of affective framing, 
assessing a key aspect of emotion regulation, peripheral stress physiology, and clinical and 
neurocognitive assessments in SCZ patients and healthy controls. This is the first study to examine 
respiratory sinus arrhythmia (RSA) in reaction to a psychosocial stressor in patients with schizophrenia 
and identify associated electrophysiological indices of aberrant arousal and stress reactivity. Results from 
this study have the potential to inform novel treatment approaches targeting the stress response to modify 
fronto-limbic oscillatory activity and consequently, improve the effectiveness of cognitive behavioral 
therapy which is reliant on successful emotion regulation strategies.  
3.2 Stress Modifies the Electrophysiological Correlates of Affective Processing in Patients with 
Schizophrenia and Healthy Controls 
Introduction 
Emotion regulation (ER) is fundamental to the development, maintenance and treatment of 
neuropsychiatric disorders, and plays a significant role in social, cognitive, and interpersonal functioning 
(Livingstone et al., 2009; Phillips et al., 2008). The emotional response is malleable and subject to 
change with cognitive context. Accordingly, ER refers to the ability to cognitively adjust physiological and 
emotional arousal to aversive events to appropriately meet situational demands. Along with negative 
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symptoms of anhedonia, avolition, apathy, and blunted effect, patients with schizophrenia exhibit 
debilitating deficits in cognitive functioning and ER which are generally resistant to pharmacotherapy, are 
associated with the poorest functional outcome, and are exacerbated by stress (Horan et al., 2013; 
Strauss et al., 2013). ER is fundamental for treatment efficacy, as cognitive behavioral therapy (CBT) and 
coping mechanisms rely on successful ER strategies (Papa et al., 2012). Implementation of ER strategies 
is critical during stressful situations; however, altering the nature of emotional responses is more 
challenging under stress, as the regulation of stress and affective systems similarly rely on fronto-limbic 
circuitry (Raio et al., 2013). While it is understood that stress interferes with ER by disrupting the dynamic 
balance of frontal executive and affective limbic circuitry, it is unclear how this processing disruption is 
reflected in peripheral physiology and neurophysiological correlates of affective network efficiency in 
patients with schizophrenia. 
Neuroimaging research has established that ER involves the recruitment of frontal executive 
networks to suppress affective limbic activity in order to control the emotional response and promote an 
adaptive functional outcome (Goldin et al., 2008; Ochsner et al., 2002, 2004; Phan et al., 2005). 
Electroencephalography (EEG) offers a powerful method for probing network level neural activity, as 
oscillations and their synchronization support interneuronal communication and the integration of 
information processing in neural networks (Roach and Mathalon, 2008). The successful execution of ER 
strategies has been shown to alter electrophysiological correlates of affective processing, including the 
late positive potential (LPP) and theta oscillatory activity, to support a more adaptive behavioral response 
(Ertl et al., 2013; Goldin et al., 2008; Hajcak et al., 2010; Kisley et al., 2011; Phillips et al., 2008). The LPP 
is an event-related potential (ERP), a voltage deflection elicited by motivationally salient stimuli, and 
serves as an index for the cognitive elaboration of aversive stimuli, as the LPP amplitude is greater for 
unpleasant stimuli relative to pleasant or neutral stimuli (Ito et al., 1998). It is possible to suppress the 
heightened LPP response to aversive stimuli by introducing cognitive framing strategies, assessing a key 
aspect of ER (Kisley et al., 2011). A novelty P3 ERP component is also elicited in response to novel and 
salient stimuli, especially during oddball paradigms which require discrimination between infrequent and 
frequent stimuli (Polich, 2007). While SCZ patients generally exhibit appropriate reports of emotional 
valence and arousal in response to unpleasant stimuli in laboratory settings (Cohen and Minor, 2008; 
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Horan et al., 2010; Strauss and Gold, 2012), they demonstrate heightened negative emotion for neutral 
and positive stimuli (Cohen and Minor, 2008; Horan et al., 2008; Strauss and Herbener, 2011), impaired 
LPP correlates of ER (Horan et al., 2013; Strauss et al., 2013), deficiencies in P3 (Andersen et al., 2016; 
van der Stelt et al., 2004, 2005), and a disturbance in the frontal executive control over affective limbic 
systems (Dichter et al., 2010; Javanbakht, 2006). 
Schizophrenia patients express profound disruptions in brain dynamics including many cortical 
areas and their connectivity, and substantial oscillatory deficiencies (Friston, 1999; Moran and Hong, 
2011; Roach and Mathalon, 2008; Uhlhaas et al., 2008; Uhlhaas and Singer, 2014). Abnormalities in the 
salience neural network are consistently reported in schizophrenia patients, including structural and 
connectivity disturbances of the anterior insula, and are associated with cognitive and negative symptoms 
(Liddle et al., 2016). Neural oscillations and their synchronization subserve the coordination and 
integration of information among brain regions and support a wide range of cognitive, perceptual and 
sensorimotor functions. In particular, theta and beta oscillations and their synchronization are 
fundamental to proficient salience and affective processing, and interact with neurotransmitter systems to 
regulate global cortical state (Ertl et al., 2013; Liddle et al., 2016). Increased theta oscillations and 
coherence between frontal and limbic regions has been demonstrated during fear conditioning and 
extinction behaviors in animals (Lesting et al., 2011; Narayanan et al., 2011), and memory processing in 
humans (Anderson et al., 2010), suggesting a crucial role for theta activity in mediating affective fronto-
limbic interactions (Javitt et al., 2008; Uhlhaas et al., 2008). Accordingly, disruptions in theta oscillatory 
activity may produce impairments in long-distance functional connectivity between frontal and limbic brain 
regions critical for affective processing (Lesting et al., 2011). Furthermore, increases in theta oscillatory 
activity, localized to frontal scalp locations, have been reported to accompany successful reappraisal of 
emotional events, representing enhanced frontal recruitment (Ertl et al., 2013). Deficiency in theta activity 
is proposed to be of particular interest in patients, as theta oscillations are prominent in the hippocampus, 
a brain region that demonstrates volumetric reductions in SCZ (Mondelli et al., 2010), and because of 
theta’s involvement in prefrontal-dependent working memory and executive function, which are impacted 
in SCZ (Uhlhaas et al., 2008).  
54 
 
Less is understood about the contributions of beta oscillations to cognitive function. Though 
traditionally thought of as a sensorimotor signal, beta oscillatory activity has been linked with novelty, 
salience detection, arousal, sensory gating, reward evaluation, personal distress, and aberrant levels of 
beta are associated with neural excitability and insula connectivity (Hong et al., 2008; Kisley and 
Cornwell, 2006; Liddle et al., 2016; Uhlhaas and Singer, 2014). Absent of environmental influences, 
patients exhibit a disruption in response hierarchy with exaggerated dopaminergic guided limbic 
responses to irrelevant stimuli (Kapur, 2003) and disproportionate neural excitability and inhibition (Inan 
et al., 2013), which promotes salience and motivated attention deficiencies (Andersen et al., 2016). 
Through interactions with dopaminergic and GABAergic systems, beta oscillatory activity plays a pivotal 
role in regulating the intricate balance of excitability and inhibition, and supports appropriate salience 
attribution. Understanding aberrant electrophysiological correlates of salience and affective processing in 
SCZ patients is crucial for identifying novel endophenotypes for psychosis and to assist in developing 
innovative therapeutic interventions with improved efficacy. 
Stress exposure interferes with frontal engagement and enhances recruitment of limbic regions, 
especially the amygdala, which in turn heightens the emotional salience and arousal for aversive stimuli, 
and promotes adaptive response selection (Oei et al., 2012). The integrity of fronto-limbic circuitry and 
network construction, and underlying oscillatory activity, is disproportionately affected by the deleterious 
effects of acute stress exposure. Stress impairs frontal-dependent processing, reflected in diminished 
frontal theta activity during working memory (Gärtner et al., 2014) and mental arithmetic (Gärtner et al., 
2015) tasks following disturbing videos with aversive content. Theta and beta activity have also been 
shown to increase following stress exposure, with enhanced theta activity following sleep deprivation 
(Alonso et al., 2015) and with stressful task complexity (Jensen and Tesche, 2002), and increased beta 
activity during a stressful Stroop task (Alonso et al., 2015). Furthermore, Chapotot and colleagues (1998) 
propose a significant coupling between natural cortisol fluctuations and beta power, suggesting a critical 
interaction between beta and stress systems in regulating arousal and alertness. Additionally, resting 
frontal EEG asymmetry is proposed to shift from greater left frontal alpha to predominately right frontal 
alpha during high stress situations (Lewis et al., 2007), further demonstrating stress induced disruptions 
in oscillatory activity. 
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 The exaggerated affective limbic engagement following stress exposure makes it more 
challenging to disengage from emotional images (Kinner et al., 2014) and to utilize emotion regulation 
strategies to minimize conditioned fear responses following a stress manipulation (Raio et al., 2013). 
Furthermore, heightened cortisol levels during stress may support emotion regulation strategies, including 
suppression and reappraisal, and relieve some interference by emotional distractors on working memory 
performance (Lam et al., 2009; Oei et al., 2012); however, the advantageous role of cortisol is potentially 
sex-dependent (Kinner et al., 2014; Kogler et al., 2014; Smeets et al., 2009). Effective implementation of 
ER strategies can promote heightened resilience following stress exposure to protect against the negative 
outcomes of stress (Troy and Mauss, 2011). Therefore, the deleterious effects of stress may be 
ameliorated by improving emotion regulation strategies and attentional control reliant on efficient fronto-
limbic oscillatory activity.  
An appropriate stress response relies on the elaborate convergence of neural regulation and 
autonomic nervous systems. The neural regulation of the autonomic nervous system conforms to a 
phylogenetical response hierarchy, with the phylogenetically newer myelinated vagal influence on the 
heart supporting social communication and calm, non-arousing behavioral states, incompatible with the 
sympathetic and unmyelinated dorsal vagal complex (Porges, 2007). The delicate balance of opposing 
inhibitory parasympathetic (vagus) and excitatory sympathetic autonomic systems determine variability in 
heart rate and physiological adaptation. Respiration influences parasympathetic vagal influence on the 
heart, generating high-frequency rhythmic heart rate oscillations associated with spontaneous breathing, 
or RSA (Porges, 2007). Frontal and limbic regions comprising the central autonomic network (CAN) 
interact with visceral afferents to modify arousal state and regulate emotion expression though the 
autonomic nervous system (Appelhans and Luecken, 2006). As emotion regulation relies on appropriate 
physiological arousal states to promote adaptive behaviors, autonomic function plays a pivotal role in the 
development and maintenance of symptom pathology. SCZ patients exhibit heightened emotional 
reactivity to stressful events (Docherty et al., 2009), and appraise positive and negative events as being 
less well managed and less controllable than controls (Horan et al., 2005). In addition to elevated stress 
sensitivity, SCZ patients demonstrate acute hyperarousal with reduced parasympathetically mediated 
HRV (RSA), heightened peripheral autonomic output (Boettger et al., 2006; Chang et al., 2009), and 
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prolonged HRV recovery in reaction to a mental arithmetic stressor (Castro et al., 2009). However, this is 
the first study, to my knowledge, to determine changes in RSA and heart rate parameters elicited by an 
acute experimental psychosocial stressor in SCZ patients, and to connect peripheral physiology with 
neurophysiological correlates of affective processing.  
The current study employed a multimodal experimental approach, incorporating neurocognitive 
and clinical assessments, EEG, and physiological measures of stress to elucidate affective fronto-limbic 
network efficiency before and after a stress manipulation. While source localization is limited, EEG offers 
a valuable tool for investigating functional brain networks by directly measuring oscillations and their 
synchronization, which represent important neurophysiological mechanisms for neuronal communication 
(Roach and Mathalon, 2008; Uhlhaas et al., 2008). The purpose of the study was to probe the integrity of 
fronto-limbic neural circuitry, indexed by theta and beta oscillatory activity, in SCZ patients and healthy 
volunteers using an emotional framing paradigm, assessing a key aspect of ER, and challenge the 
circuitry using a psychosocial stress manipulation, reliant on the interaction of frontal and limbic brain 
regions, to see how well the affective system adapts to, and recovers from, stress exposure. The study 
investigated the effect of stress on modulating the LPP amplitude and oscillatory indices of ER to aversive 
stimuli, and established the relationship between stress, electrophysiological correlates of ER, and clinical 
symptoms.  
Patients are expected to exhibit deficits in emotional framing and cognitive control over affective 
circuitry, with difficulty alleviating the LPP response to aversive stimuli following positive framing and 
reduced frontal theta activity during the positive framing condition, which requires additional cognitive 
resources to modulate the emotional response. In addition, enhanced beta activity is expected to 
accompany patients’ reported inability to suppress the limbic system during ER. Psychosocial stress 
exposure is predicted to disrupt oscillatory and ERP indices of ER in patients and control participants, 
with difficulty reducing the LPP response to aversive stimuli and divergent reductions in theta and 
enhanced beta oscillatory activity. The electrophysiological response in controls following stress is 
predicted to mimic SCZ patients’ electrophysiological profile before stress. However, stress is expected to 
have a more profound effect on EEG correlates in patients relative to controls. Consistent with previous 
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literature, patients are expected to exhibit overall heightened stress reactivity relative to controls with 
greater heart rate and reduced RSA and heart period, a blunted stress response with less physiological 
fluctuation during and following stress exposure, and a longer recovery of amplified stress levels. 
Furthermore, symptom severity and heightened stress reactivity is predicted to associate with aberrant 
neural synchrony, indexed by diminished frontal theta and enhanced parietal beta. 
Method 
Participants 
 Participants consisted of 21 patients diagnosed with a schizophrenia-spectrum illness (SCZ) and 
21 healthy control (CON) individuals, all male between the ages of 18 to 35 years. Recruitment was 
restricted to males to prevent gonadal hormone interactions with HPA activity (Foley and Kirschbaum, 
2010; Kirschbaum et al., 1992), and because women exhibit distinct neural correlates of affective 
processing (Gardener et al., 2013; Stevens and Hamann, 2012; Whittle et al., 2011). Patients were 
recruited from the Outreach and Support Intervention Services (OASIS) clinic in Carrboro, North Carolina, 
and referred to the study by their treating psychiatrist, who judged them stable and fit to volunteer in the 
study. CON participants were recruited from the Orange County community via flyers. Patients met 
criteria for schizophrenia (n = 14), schizoaffective (n = 4), or schizophreniform (n = 3) disorder as 
assessed by the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition (SCID DSM-IV), and diagnoses were confirmed using diagnostic criteria outlined in DSM-V 
(American Psychiatric Association, 2013; First et al., 1995). All patients were medicated with first-
generation (n = 2) or second-generation (n = 19) antipsychotics and had stable symptoms. Control 
participants had no DSM-IV Axis I diagnosis, were not taking antipsychotic medications, and did not have 
first-degree relatives with a schizophrenia-spectrum illness diagnosis. All participants spoke English, had 
normal or corrected vision, and no history of neurological disorders. Participants received $20.00 per hour 
for their participation, amounting to $100.00 total. Informed consent was provided in accordance with the 
University of North Carolina at Chapel Hill Institutional Review Board.  
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Measures 
Clinical Assessments 
 Along with the SCID, all participants were given the Clinical Assessment Interview for Negative 
Symptoms (CAINS) to assess motivation, pleasure and emotional expression (Kring et al., 2013), and the 
Alcohol Use Scale/ Drug Use Scale (AUS/DUS) (Drake et al., 1989). Patients were additionally 
administered the Structured Interview for Positive and Negative Syndrome Scale (SCI-PANSS) to assess 
symptom severity along positive, negative and general symptom subscales (Opler et al., 1992). 
Neurocognitive Tests 
 Participants performed a computerized battery of neurocognitive assessments, including the 
North American Adult Reading Test (NAART) (Uttl, 2002) to estimate intelligence, the Continuous 
Performance Test- Identical Pairs test (CPT-IP) (Cornblatt et al., 1989) to measure effort and attention, 
Auditory Verbal Learning Test (AVLT) (Geffen et al., 1994) to evaluate learning and memory, Visuospatial 
Sequencing Test (VST) to assess working memory, and the Stroop Test to evaluate executive functioning 
(van Erp et al., 2015). Neurocognitive assessments were administered through the Computerized 
Multiphasic Interactive Neurocognitive DualDisplay System (CMINDS) (O’Halloran et al., 2008). 
Stress and Affect Questionnaires 
 Self-report ratings of stress and affect were collected using the Daily Stress Inventory (DSI) 
(Brantley et al., 1987) to evaluate frequency and content of daily stress, the Perceived Stress Scale 
(PSS) (Cohen et al., 1983) to examine experienced levels of stress, the Emotion Regulation 
Questionnaire (ERQ) (Gross and John, 2003) to evaluate cognitive reappraisal and expressive 
suppression behaviors, and subjective levels of stress and affect were measured concurrently with saliva 
collections using 10-point Likert scales on the Subjective Stress/Affect Rating form (SSR). Additionally, 
the Positive and Negative Affect Schedule (PANAS) was administered at the beginning and end of the 
session to assess current state of affect (Watson and Clark, 1999). 
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Stress Protocol 
 The acute psychosocial stressor, Trier Social Stress Test (TSST), was implemented by 
combining the preparation and delivery of a speech with challenging mental arithmetic performance in 
front of a committee (Kirschbaum et al., 1993). After a three-minute preparation period, the participants 
were asked to give a five-minute mock job interview, followed by five minutes of challenging serial 
subtraction in front of an intimidating committee. The committee was introduced as “academic experts” 
trained in evaluating nonverbal behavior, and were instructed to refrain from providing any feedback. The 
participants were told that they were being video recorded to later evaluate their performance. Six saliva 
samples were collected from each participant to assess both salivary cortisol (sCORT) and salivary alpha 
amylase (sAA): a baseline sample before the experiment begins, before and after the onset of the 
stressor, at 25 minutes post stressor and two additional samples collected 45 and 80 minutes following 
stress onset to capture the recovery of the stress response. Saliva was collected using a salivary cotton 
swab (Salivette-Sarstedt, Germany) which the participant inserted under their tongue for two minutes. 
Experimenter instructed participants to saturate the cotton swab with as much saliva as possible. sCORT 
and sAA analyses are not included in the current report. Electrocardiogram (ECG) was collected 
simultaneously with each task and the stressor. In addition to the saliva samples, participants completed 
SSR forms for 5 different adjectives (stressed, happy, irritated, unhappy, overwhelmed) at each of the six 
saliva collection time-points to further validate the stress manipulation.  
Emotional Oddball Framing Paradigm  
 An emotional oddball framing paradigm, modeled after Kisley and colleagues (2011), was 
employed while EEG was recorded (Figure 3.1). A series of five images selected from the International 
Affective Picture System (IAPS) database comprised a block. IAPS images are complex images with 
standardized ratings from adults on a scale of 1-9 for valence and arousal, with higher numbers reflecting 
more positive valence and higher arousal (Lang et al., 2008). The average (SD) valence and arousal 
ratings for the aversive stimuli, with images of mutilation, disease, and human violence, were 2.2 (1.5) 
and 5.8 (2.3), respectively, whereas neutral images depicting household items and neutral human faces 
had average (SD) valence and arousal ratings of 4.7 (1.4) and 3.6 (2.0), respectively. Each block 
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consisted of a target stimulus, which depicted aversive or neutral emotional content, embedded among 
four neutral, non-arousing stimuli. Target stimuli were located in the third, fourth or fifth image slot to 
ensure that target images were followed by at least two neutral “fillers”. Neutral and aversive blocks were 
matched for human content. Images were presented for 1000 ms, followed by a framing cue instructing 
the participant to respond on a button box to indicate whether the image presented previously was either 
“positive” or “negative” according to the condition. The framing cue was presented until the participants 
made a response (up to 5000 ms), and had variable interstimulus intervals between 400-600 ms. A 
neutral framing condition was performed first, and required participants to determine whether there was 
an animal in the image presented previously. Animals were depicted in both neutral and negative 
contexts. Each condition lasted approximately 10 minutes and contained the random selection of 30 
neutral blocks and 30 aversive blocks. A total of four emotional framing conditions (positive and negative 
before and after stressor) were administered to each participant and the order of conditions was 
counterbalanced between participants. Participants used self-assessment manikins (SAMs) to rate 20 
representative images on valence and arousal at the end of the EEG session. 
Resting State Recordings 
 Participants were instructed to focus (eyes open) on a fixation cross for three minutes and remain 
relaxed and still as possible while resting state EEG and ECG measurements were performed. Resting 
state recordings were administered at the beginning of the EEG session, directly before the stressor, 
immediately following the stressor and at the conclusion of the EEG session.   
Procedure 
 The experiment included a clinical and neurocognitive assessment session and an EEG 
recording session, primarily scheduled on separate days. Refer to Figure 3.2 for a diagram of the study 
design. The EEG session was performed at 1:00 PM for all participants to obtain stable endogenous 
cortisol levels and capture the most accurate endocrine response to the stress manipulation (Allen et al., 
2014), whereas the clinical session occurred at variable times throughout the day. Participants were 
allowed to smoke and consume caffeine up until two hours prior to the experiment in accordance with 
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their habitual smoking and drinking patterns. After providing informed consent during the clinical and 
neurocognitive session, clinical interviews and computerized neurocognitive tests were performed for 
approximately two hours.   
Participants first completed a urinary toxicology screen upon arrival at the EEG session and had 
their head measured for an EEG net, followed by the first saliva collection and SSR and PANAS ratings. 
After the EEG net and ECG electrode placement, the participants performed a resting state and the 
neutral framing condition. The TSST was introduced between two sets of positive and negative framing 
conditions. After the final framing condition, participants completed a collection of questionnaires and 
used SAM to provide valence and arousal ratings for 20 select images (15 aversive, 5 neutral) (Bradley 
and Lang, 1994). The EEG session lasted approximately three hours.   
Electrophysiological and ECG Recording Parameters 
 The EEG was acquired using a 128-channel Hydrocel Geodesic Sensor Net (Electrical 
Geodesics Inc., Eugene, OR). Placement of electrodes conformed to the International 10-20 System 
(Klem et al., 1999). Net Station 4.5.1 software on an iMac computer, along with a Net Amps 300 (1.0.1) 
amplifier, were used for EEG recordings. Data were filtered online at 0.05 Hz with a sampling rate of 1000 
Hz (except for 5 participants, which were digitized at 250 Hz), and were referenced online to a central 
electrode (Cz). Impedances were maintained below 50 KΩ for the duration of the session. E-Prime 2.0 
with E-Studio 2.0.8.74 was used to program the tasks and events were synchronized with the EEG data 
using an E-Prime extension for Net Station. Data were exported from Net Station in simple binary format 
and uploaded in EEGLAB version 13.4.4b, a Matlab open source toolbox for processing and analysis 
(Delorme and Makeig, 2004). 
 Three self-adhering electrodes (Ultratrace) were hand placed directly below collar bone, over rib 
cage and above hip bone to monitor ECG with Biopac (Biopac Systems, Inc., CA) and sampled at 1000 
Hz by AcqKnowledge acquisition software (Biopac Systems, Inc., CA).  
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Neurocognitive Data Analysis 
Neurocognitive scores were standardized using a z-transform to generate composite scores for 
memory and executive function to use in further analyses. A description of outcome variables and 
composite score calculations are presented in Figure 3.3. NAART was used to estimate verbal intellectual 
ability by taking the total number of correctly identified words. 
Behavioral Data and Self-Assessment Manikin (SAM) Ratings Analysis 
SAM valence and arousal ratings for 20 representative images were averaged separately for 
aversive (15 images) and neutral (5 images) stimulus types. Response latency (reaction time (RT) 
measurements of the framing categorization were averaged across condition for each stimulus type, 
collapsed over correct and incorrect trials. Accuracy (percent correct) for the correct categorization of 
aversive images during the negative framing conditions (before and after stress) was also assessed. 
ERP Data Analysis 
 EEG datasets were down-sampled to 250 Hz, high pass filtered at 0.1 Hz, and low pass filtered at 
55 Hz using a Hann filter (78 filter order with transition bandwidth of 10) with -6 dB cutoff to remove 60 Hz 
line noise. Bad channels were detected and removed using the EEGLAB processing extension, 
trimOutlier (Lee & Miyakoshi, SCCN, INC, UCSD), and channels were interpolated before manually 
rejecting segments of data with major artifacts. EEG data were re-referenced to the average and 
continuous EEG data from 56 selected channels (emitting electrodes toward the edge of the net) were 
subsequently segmented into epochs spanning from 200 ms before to 1200 ms post stimulus onset using 
the ERPLAB toolbox (Luck and Lopez-Calderon, UC Davis). Epochs containing amplitudes exceeding 
±150 µV or contained abnormally distributed data were excluded. ERPs were obtained by averaging the 
baseline corrected (-200 to 0 ms) epochs for each participant for each stimulus type. The average 
number of accepted trials was 24.84 (SD = 2.24) and did not differ by group (F(1,41) = 0.67, P = 0.42). 
Grand average waveforms were generated and low pass filtered at 15 Hz. A cluster of four parietal 
channels were averaged together to represent the region of interest (electrodes: Pz = 62,71,72,76; Figure 
3.4), approximating clusters that have been used in a previous study (McEvoy et al., 2015). The P3 
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component was defined as the average amplitude between 250 and 500 ms, and the LPP was analyzed 
between 400 and 1000 ms following stimulus onset, averaged over the parietal cluster.  
EEG Data Analysis 
For time-frequency analyses, EEG data were down-sampled to 250 Hz, and high and low pass 
filtered between 1 and 55 Hz (as described above). Raw data were cleaned and bad channels were 
removed using the EEGLAB extension, clean_rawdata with a standard deviation of 20 (Miyakoshi and 
Kothe, 2013). Data were further subjected to manual inspection and rejection of major artifacts before re-
referencing the data to average channel values. An independent component analysis was performed, 
followed by the interpolation of the removed bad channels. Epochs spanning 1 second before and 2 
seconds after stimulus onset were generated for each stimulus type and epochs with amplitudes 
exceeding ±500 µV (does not capture blinks) and containing abnormally distributed data were rejected. 
Cleaned, epoched data for each condition and stimulus type for all participants were loaded into an 
EEGLAB STUDY to compute the time-frequency transform using the ‘newtimef’ function and extract non-
phase locked event-related spectral perturbations (ERSP). The decomposition was performed using a 
wavelet transform with a 3-cycle wavelet to yield Time X Frequency spectrograms with frequencies from 3 
to 50 Hz. Peak event-related spectral perturbation (ERSP) in theta (4-8 Hz) and beta (13-30 Hz) 
frequency bands was then extracted from the pre-computed matrices between 100-500 ms and 600-1000 
ms post stimulus onset from select electrodes (F3, F4, Fz, C3, C4, Cz, P3, P4, Pz).  
ECG Data Analysis 
Inter-beat-intervals (IBIs) were extracted from the raw ECG data using in-house software 
implemented through LabView2014 version 14.0f2 (developed by Maria Davila and Greg Lewis, UNC). 
IBIs were visually inspected and missed R-wave detections and errors were corrected using CardioEdit 
(Brain-Body Center, Chicago, IL). RSA was quantified using standard adult parameters that define RSA 
from frequencies between 0.12 to 0.40 Hz associated with spontaneous respiration, and analyzed using 
the Porges-Bohrer method of RSA analysis in CardioBatch (Brain-Body Center, Chicago, IL). Filtered time 
series were divided into 30 second epochs, the variance of each epoch was transformed with a natural 
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logarithm (ln(ms2)) to calculate the RSA amplitude, and the average epoch value was used to estimate 
RSA and characterize individual differences. Average heart period (HP), interval between successive R-
waves (ms) and heart rate (HR; bpm) were also calculated using CardioBatch software. While ECG was 
collected throughout the EEG session, RSA, HP and HR were specifically analyzed during the baseline 
resting state (rsb, 3 minutes), the resting state prior to stress exposure (rs1, 3 minutes), TSST 
(preparation (3 minutes), speech (5 minutes), math (5 minutes), the resting state following the stressor 
(rs2, 3 minutes) and during the final resting state recording (rs3, 3 minutes). 
Statistical Analyses 
Statistical analyses were performed using PASW Statistical Software, version 18.0 (SPSS Inc, 
2009). Demographic, neurocognitive, clinical and self-report questionnaire data were analyzed using 
analyses of variance (ANOVAs) for continuous variables, and race was assessed using a chi-square test. 
SAM ratings of valence and arousal for neutral and aversive stimuli were analyzed using a Group X 
Stimulus (aversive, neutral) X SAM rating (valence, arousal) repeated-measures (rm) ANOVA, and 
PANAS affect ratings were assessed using a Group X Affect (positive, negative) X Time (beginning, end) 
rm-ANOVA. 
Valence was evaluated during the neutral (animal) framing condition for ERP (P3, LPP) and EEG 
(theta, beta) variables separately using a Group (Controls, SCZ patients) X Stimulus (aversive, neutral) 
rm-ANOVA. The effect of framing on processing aversive and neutral stimuli before stress was examined 
using a Group X Framing (neutral, positive, negative) X Stimulus (aversive, neutral) rm-ANOVA, and the 
influence of stress reactivity on behavioral and EEG correlates of affective processing was evaluated by 
performing a Group X Framing (positive, negative) X Stimulus (aversive, neutral) X Stress (before stress, 
after stress) rm-ANOVA separately for ERP (P3, LPP), EEG (theta, beta) and reaction time (RT).  
ECG measures were analyzed using a Group (Controls, SCZ patients) X Measure (6 time points) 
rm-ANOVA for RSA, HP and HR separately. Polynomial and repeated within subject contrasts were 
performed to evaluate linear and quadratic trends and the comparison of adjacent levels, respectively. 
While age did not differ between groups, there are physiological changes with age; therefore, age was 
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entered as a covariate for the ECG analyses (O’Brien et al., 1986). RSA, HR and HP were also assessed 
by generating averaged before stress (rsb, rs1), during stress (TSST) and after stress (rs2, rs3) 
composite scores and performing a Group X Measure (RSA, HR, HP) X Time (before stress, during 
stress, after stress) rm-ANOVA. Self-report affect/stress ratings were assessed using a Group X Affect 
(Happy, Stressed, Depressed, Overwhelmed, Irritated) X Time (baseline, before stress, after stress, 
recovery 1, recovery 2, recovery 3) rm-ANOVA with repeated within subject contrasts. Post-hoc pairwise 
comparisons were Bonferroni-corrected for multiple comparisons and Greenhouse-Geisser epsilon 
corrections were used when the sphericity assumption was violated for all rm-ANOVA analyses. 
CAINS scores conformed to a bimodal distribution, therefore, correlation analyses were 
performed in SCZ patients only. The relationship between CAINS scores (motivation and pleasure, 
expression), neurocognitive measures (memory and executive function composite scores, NAART), 
physiological stress measures (RSA, HR, HP before, during and after stress), were correlated with the 
early frontal theta and late parietal beta ERSP responses for aversive stimuli (collapsed over positive and 
negative framing conditions) before and after stress using Spearman’s rank correlation analysis. 
Additionally, positive, negative and general PANSS subscales were correlated with ECG measures (RSA, 
HR, HP) before, during and after stress and early frontal theta and late parietal beta activity for aversive 
stimuli before and after stress.  
Results 
Demographics, Neurocognitive and Clinical Assessments 
Age, handedness, and average parental education did not differ between control and SCZ 
patients (P > 0.05); however, controls received more years of education than patients (F(1,41) = 14.53, P 
< 0.001) and groups marginally differed by race (Χ2 (3, n = 42) = 7.13, P = 0.07). Patients expressed 
greater negative symptom severity measured by CAINS motivation and pleasure and expression scores 
compared with controls, and demonstrated an inferior performance on all neurocognitive assessments 
(Fs > 6, Ps < 0.05) (Table 3.1). Furthermore, groups did not differ on subjective measures of stress (DSI, 
PSS) and affect (PANAS, ERQ), or self-reported drug and alcohol use (AUS/DUS) (P > 0.05) (Table 3.2). 
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Stress Reactivity (SSR, ECG) 
Subjective Stress/Affect Rating (SSR) 
Main effects of Affect (F(1.74, 60.73) = 58.00, P < 0.01, ηp2 = 0.62) and Time (F(3.18, 111.37) = 
17.43, P < 0.01, ηp2 = 0.33) and a Time X Affect interaction (F(7.63, 267.20) = 14.89, P < 0.001, ηp2 = 
0.30) indicated differential experiences of affect which fluctuated throughout the EEG session. Stress 
exposure elicited changes in subjective measures of affect, as planned contrasts demonstrated a 
significant linear increase in subjective affect rating between “before stress” and “after stress” (F(1, 35) = 
10.39, P < 0.01, ηp2 = 0.23), and “after stress” and “recovery 1” time-points (F(1, 35) = 52.14, P < 0.001, 
ηp2 = 0.60). Pairwise comparisons revealed that ratings of “happy” deteriorated (P < 0.001) while ratings 
of “stressed” (P < 0.01) and “irritated” (P < 0.01) increased following stress. Additionally, SCZ patients 
exhibited greater levels of “unhappy” during the “recovery 2” time-point than controls (P = 0.03) (Figure 
3.5). 
Positive and Negative Affect Schedule 
 Ratings for positive affect were greater than for negative affect (F(1, 35) = 48.95, P < 0.001, ηp2 = 
0.58), and ratings significantly decreased following stress (F(1, 35) = 18.69, P < 0.001, ηp2 = 0.35). 
Furthermore, stress exposure reduced positive affect disproportionately, reflected in a Affect X Time 
interaction (F(1, 35) = 25.63, P < 0.001, ηp2 = 0.42). 
Heart Period 
Heart period (HP) decreased significantly during stress exposure (F(2.48, 69.49) = 3.88, P = 0.02, 
ηp2 = 0.12) according to a quadratic trend (F(1, 28) = 5.69, P = 0.02, ηp2 = 0.17), thus validating the stress 
manipulation. The pattern of HP variation differed significantly between groups (F(1, 28) = 9.16, P = 0.01, 
ηp2 = 0.25), with patients demonstrating a blunted response to the acute stressor. Controls exhibited a 
stronger decrease in HP from “rs1” to “TSST_prep” compared with patients (F(1, 28) = 7.49, P = 0.01, ηp2 
= 0.21), represented in planned within-subject contrasts (Figure 3.6a). 
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Heart Rate 
A main effect of heart rate was found (F(2.83, 76.30) = 3.61, P = 0.02, ηp2 = 0.12) conforming to a 
quadratic trend (F(1, 27) = 4.68, P = 0.04, ηp2 = 0.15), which differed by group (F(1, 27) = 5.63, P = 0.03, 
ηp2 = 0.17). Planned within-subjects contrasts of heart rate over time did not produce any significant 
results (Figure 3.6b). 
Respiratory Sinus Arrhythmia 
Planned contrasts demonstrated a significant difference in the slop of RSA between groups (F(1, 
27) = 4.68, P = 0.04, ηp2 = 0.15), while within-subject contrasts suggest that the difference between RSA 
at baseline and the RSA measured at recovery 3 was greater for SCZ patients (F(1, 27) = 11.10, P < 
0.01, ηp2 = 0.29). No significant main effects of Group or RSA were found (Figure 3.6c). 
Combined Physiological Measurements 
Acute stress exposure induced changes in ECG (RSA, HP, HR) measurements (F(1.70, 61.18) = 
44.44, P < 0.001, ηp2 = 0.55) which differed significantly by group (F(1.70, 61.18) = 6.30, P = 0.01, ηp2 = 
0.15). Patients exhibited heightened stress reactivity with greater HR and reduced HP before (HR, F(1, 
36) = 8.73, P = 0.01, ηp2 = 0.20; HP, F(1, 36) = 8.45, P = 0.01, ηp2 = 0.19) and after (HR, F(1, 36) = 6.03, 
P = 0.02, ηp2 = 0.14; HP, F(1, 36) = 6.25, P = 0.02, ηp2 = 0.15) stress, along with reduced baseline RSA 
levels (F(1, 36) = 6.52, P = 0.02, ηp2 = 0.15) (Figure 3.6d).   
Emotional Oddball Framing Task  
Behavioral Results 
 Response latency was greater overall for neutral relative to aversive images before stress (F(1, 
37) = 9.83, P < 0.01, ηp2 = 0.21), except for the animal framing condition, in which a Framing X Stimulus 
interaction indicated reaction times (RTs) were greater for aversive stimuli (F(1.45, 53.63) = 3.51, P = 
0.05, ηp2 = 0.09). Increased RTs were observed during the negative condition compared with the animal 
and positive conditions before stress (F(2, 74) = 8.46, P < 0.001, ηp2 = 0.19). While the same pattern of 
enhanced RTs for neutral stimuli persisted following the stress manipulation (F(1, 33) = 11.96, P < 0.01, 
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ηp2 = 0.27), an overall reduction in RT (F(1, 33) = 11.80, P < 0.01, ηp2 = .26), especially for the negative 
condition (F(1, 33) = 4.45, P = 0.04, ηp2 = 0.12), was observed. Accuracy was greater for aversive stimuli 
during the negative framing condition compared with neutral stimuli (F(1, 37) = 6.98, P = 0.01, ηp2 = 0.16); 
however, correct categorization of neutral stimuli during the negative condition became more challenging 
after stress exposure (F(1, 37) = 8.93, P = 0.01, ηp2 = 0.19) (Table 3.3). 
Self-Assessment Manikin (SAM) Ratings 
A Stimulus X SAM rating interaction confirmed that aversive images were rated as more negative 
and arousing than neutral images (F(1, 35) = 70.66, P < 0.001, ηp2 = 0.67). A Group X Stimulus 
interaction suggested that patients rated aversive images as being more negative, yet less arousing than 
control participants (F(1, 35) = 5.14, P = 0.03, ηp2 = 0.13) (Table 3.3). 
ERP 
A significant main effect of Stimulus for P3 (F(1, 39) = 13.12, P < 0.01, ηp2 = 0.25) and LPP (F(1, 
39) = 6.51, P = 0.02, ηp2 = 0.14) confirmed that the response to aversive stimuli was greater than that for 
neutral stimuli during the neutral (animal) framing condition (Figure 3.7). A Stimulus X Framing interaction 
indicated a unique enhancement of the P3 amplitude for aversive stimuli compared to neutral stimuli 
during the animal framing condition, which was not observed for negative and positive framing conditions 
before stress (F(2, 78) = 4.99, P = 0.01, ηp2 = 0.11). A Stimulus main effect revealed the LPP amplitude 
for aversive stimuli was greater than the amplitude for neutral stimuli across animal, positive and negative 
framing conditions before stress (F(1, 39) = 9.28, P < 0.01, ηp2 = 0.19), and positive and negative 
conditions after stress (F(1, 37) = 11.30, P < 0.01, ηp2 = 0.23). No additional main effects or interactions 
were found, including group or stress effects for P3 or LPP components (Ps > 0.05) (Figure 3.8). 
EEG 
A significant main effect of Group for theta was found indicating reduced early frontal theta ERSP 
for SCZ patients compared with controls before stress (F(1, 39) = 6.52, P = 0.02, ηp2 = 0.14) and after 
stress (F(1, 37) = 5.15, P = 0.03, ηp2 = 0.12). Planned pairwise comparisons demonstrated that patients 
exhibited significant reductions in theta ERSP specifically for aversive stimuli compared with controls 
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during positive (F(1, 39) = 6.33, P = 0.02, ηp2 = 0.14) and negative (F(1, 39) = 7.30, P = 0.01, ηp2 = 0.16) 
conditions before stress (Figure 3.9). An effect of Stress (F(1, 37) = 4.22, P = 0.05, ηp2 = 0.10) and a 
Stress X Stimulus interaction (F(1, 37) = 5.05, P = 0.03, ηp2 = 0.12) indicated that theta ERSP was greater 
after stress exposure, especially for aversive stimuli (Figure 3.10).  
A decrease in beta ERSP, or event-related desynchronization (ERD), was found for neutral and 
aversive stimuli across all conditions for SCZ patients and controls. A Stimulus effect for beta suggested 
that beta ERD was stronger for emotional stimuli before (F (1, 39) = 5.29, P = 0.03, ηp2 = 0.12) and after 
stress (F(1, 37) = 16.43, P < 0.001, ηp2 = 0.31). Pairwise comparisons revealed patients exhibited reduced 
beta ERD for aversive stimuli during the negative framing condition before stress (F(1, 39) = 4.78, P = 
0.04, ηp2 = 0.11) (Figure 3.11). A Stimulus X Stress interaction was found indicating reduced beta ERD for 
neutral stimuli after stress (F(1, 37) = 4.06, P = 0.05, ηp2 = 0.10). No additional main effects or interactions 
were found (Figure 3.12). 
Relationship Between Clinical, Neurocognitive, Stress and EEG Activity 
Spearman’s rank correlations revealed that reduced frontal theta for aversive stimuli before stress 
was associated with inferior memory performance (rs = 0.47, P = 0.04, N = 19) and enhanced CAINS 
motivation and pleasure symptom severity (rs = -0.65, P = 0.01, N = 17) in SCZ patients. Increased 
parietal beta activity (decreased beta ERD) for aversive stimuli before stress was related to decreased HP 
and RSA, and increased HR (indicative of greater stress levels) before (HP, rs = -0.56, P = 0.01, N = 19; 
RSA, rs = -0.58, P = 0.01, N = 19; HR, rs = 0.56, P = 0.01, N = 19) and during stress (HP, rs = -0.59, P = 
0.01, N = 19; RSA, rs = -0.59, P = 0.01, N = 19; HR, rs = 0.56, P = 0.01, N = 19). PANSS symptom 
severity on the positive subscale was associated with decreased HP before (rs = -0.67, P = 0.002, N = 
19), during (rs = -0.56, P = 0.01, N = 19) and after (rs = -0.46, P = 0.05, N = 19) stress, and enhanced 
parietal beta for aversive stimuli after stress (rs = 0.47, P = 0.05, N = 19) (selected correlations are 
presented in Figure 3.13). 
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Discussion 
The effect of psychosocial stress on electrophysiological correlates of ER was investigated in 
patients with SCZ and healthy volunteers using a multimodal design. SCZ patients demonstrated 
deficiencies in employing frontal control mechanisms to dampen affective neural circuits, evident by a 
deficit in frontal theta and weakened beta desynchronization for aversive stimuli. Enhancement of theta 
and reduced beta ERD accompanied the stress manipulation, indicative of a shift to a more arousing, 
excitable state and a disruption in affective network efficiency. Along with a heightened stress profile at 
baseline, patients exhibited a maladaptive stress response which was associated with CAINS symptoms 
of expression and motivation and pleasure, positive symptom severity, and beta excitability. This is the 
first study to examine the effect of psychosocial stress on electrophysiological correlates of emotional 
framing in patients with schizophrenia and control individuals, and to correlate peripheral physiological 
measures of stress with oscillatory EEG indices of ER. 
Validation of the psychosocial stress test (TSST) protocol to effectively elicit a stress response in 
all participants was established, as evident by contradictory shifts in subjective happiness and stress, and 
an autonomic profile of sympathetic activation and parasympathetic inhibition with increased HR, and 
decreased HP. Despite similar subjective ratings of stress and affect experience throughout the stress 
manipulation, patients exhibited enhanced baseline levels of stress, with reduced RSA and HP and 
increased HR. The aberrant physiological measures of stress at baseline in patients may reflect impaired 
parasympathetic input to the heart, consistent with a previous report of disrupted heart rate variability 
(HRV) in SCZ patients (Castro et al., 2008). Additionally, patients demonstrated blunted HP and HR 
response patterns to stress exposure, in accordance with hypotheses and previous reports of blunted 
cortisol and electrodermal responses in SCZ patients (Brenner et al., 2009). However, the unique 
progression in RSA from baseline to post-stress recovery in patients was unexpected and inconsistent 
with previous reports of a delayed recovery of HRV in patients (Castro et al., 2008). In contrast to Castro 
and colleagues’ assessment of HRV during 14 minutes of stress and recovery, the current study tracked 
changes in RSA throughout the entire three-hour recording session, which along with differential analysis 
parameters for RSA and HRV, could account for the discrepancy in results. Controls exhibited successful 
RSA suppression during stress and following the stress manipulation, indicating appropriate vagal 
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withdrawal to concentrate mobilization and defensive efforts (Porges, 2007). Enhanced RSA and reliable 
RSA suppression have been associated with superior executive functioning and cognitive performance 
(Hansen et al., 2003, 2004), social engagement (Hamilton et al., 2014) and emotion regulation processes 
(Appelhans and Luecken, 2006; Lane et al., 2009). In patients, reduced baseline RSA levels and the 
inability to suppress RSA following stress may reflect a maladaptive stress response, and index deficient 
autonomic flexibility and neural regulation of visceral state. Consistent with the Jacksonian principle of 
dissolution, when higher order myelinated vagal motor pathways are ineffective at disinhibiting the vagal 
influence to support calm, social behaviors, an unmyelinated vagal component dominates, optimizing 
defensive, avoidance behaviors (Porges, 2007). Accordingly, a maladaptive stress response was found to 
correlate with inferior executive function and heightened symptoms of expression and positive symptom 
severity in patients, consistent with the association between autonomic dysregulation and psychiatric 
symptoms (Henry et al., 2010). 
Emotional regulation strategies require frontal engagement to manipulate the perception of 
evocative stimuli and determine whether the image was consistent with the contextual framework 
provided, reflected in elevated frontal theta oscillatory activity (Ertl et al., 2013). Examining oscillatory 
activity underlying fronto-limbic-mediated ER processes is a valuable method for discerning network 
efficiency, as the synchronization of neural oscillations support the integration of information in neural 
networks. While the exact function of theta during ER is unclear, theta has been proposed to underlie 
PFC-dependent cognitive control and to be responsible for coordinating attentional resources for specific 
task demands (Cavanagh and Frank, 2014). The task employed was not sufficiently robust to 
demonstrate significant framing effects; however, framing appeared to modify the electrophysiological 
response to aversive and neutral stimuli, reflected in the reduced LPP amplitude during the positive 
condition compared to the negative condition before stress. Furthermore, frontal theta activity was greater 
during the positive framing of aversive stimuli in controls as predicted, despite not reaching significance. 
Accordingly, theta activity may support enhanced cognitive and attention demands required to down-
regulate the emotional response. Neutral images and aversive images framed in the positive condition 
required additional attentional resources, as they were not consistent with the contextual frame, resulting 
in minimal increases in the P3 amplitude and increased behavioral response latency for neutral images 
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during the emotional framing tasks. The P3 component is more susceptible to changes in attentional 
demand relative to the LPP amplitude (Hajcak et al., 2007; Kleih et al., 2010; Polich, 2007), which could 
explain why marginal emotional framing effects were found for the LPP but not for the P3 component. An 
independent component analysis could be employed to further differentiate between P3 and LPP and 
underlying oscillatory activity. Without first establishing clear framing effects before stress, it was difficult 
to determine whether acute stress exposure disrupted the regulation of ERP amplitude in response to 
aversive stimuli. Thus, stress influences on the ERP correlates of emotional framing will require further 
investigation in SCZ patients. 
Despite minimal framing modifications of the EEG signal in the emotional oddball framing 
paradigm, valence discrimination was intact. The animal framing paradigm resembled a traditional oddball 
paradigm with novel infrequent aversive targets and frequent neutral stimuli, and appropriately elicited 
enhanced P3 and LPP amplitudes for aversive stimuli relative to neutral stimuli. The greater ERP 
responses for aversive stimuli reflected the appropriate cognitive elaboration of aversive, emotional 
events. However, there was not a significant difference between the P3 response for aversive and neutral 
stimuli in the emotional framing conditions. Given these results, it is evident that valence discrimination 
diminished with the introduction of emotional framing cues, possibly indicating that the emotional context 
augmented the electrophysiological response to neutral images. Furthermore, the response latency for 
aversive stimuli was greater than that for neutral stimuli in the neutral condition, which was not found 
during the emotional framing tasks, further supporting the differential effect of emotional framing on the 
electrophysiological response to neutral stimuli.   
Participants appropriately rated the aversive stimuli as being more negative and arousing than 
the neutral stimuli. However, compared to control participants, patients rated aversive images as being 
more negative, yet less arousing, indicating an aberrant arousal response. The elevated “in-the-moment” 
ratings of negative emotions when exposed to unpleasant stimuli is consistent with previous reports of 
valence attribution in SCZ patients (Cohen and Minor, 2008; Strauss and Gold, 2012), though it is unclear 
why patients experienced the aversive images as being less arousing. It is possible that stress exposure 
influenced the arousal rating, as the SAM assessment was completed at the end of the session. The low 
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subjective rating of arousal for aversive stimuli is consistent with the inability to suppress RSA observed in 
patients, further promoting maladaptive arousal and behavioral states. Future studies should determine 
whether SAM ratings are influenced by stress and framing condition.  
SCZ patients exhibited an overall deficit in frontal theta activity, especially for aversive stimuli, 
before and after the stress manipulation. Reduced frontal theta oscillatory activity may indicate deficient 
neuronal participation and synaptic connectivity, and aberrant frontal connectivity, as slow-wave 
oscillations are critical for integrating information processed in remote brain regions (Uhlhaas and Singer, 
2014). Additionally, reduced theta oscillations may indicate a global deficit in cortical communication, 
consistent with schizophrenia being a disconnection syndrome (Fitzsimmons et al., 2013; Friston, 1999). 
Frontal theta activity is proposed to underlie PFC and ACC engagement during working memory, 
cognitive control and performance monitoring (Gärtner et al., 2014; Gevins et al., 1997; Onton et al., 
2005), and these regions have been reported to be functionally and structurally impaired in SCZ (van der 
Meer et al., 2014). Therefore, it is not surprising that deficiencies in theta activity were observed in SCZ 
patients, and is consistent with previous reports of aberrant theta oscillatory activity in recent onset SCZ 
patients (Andersen et al., In preparation) and adolescents at familial risk for SCZ (Donkers et al., 2011). 
Furthermore, the observed relationship between greater frontal theta activity in response to aversive 
stimuli during an emotional oddball framing task and superior memory performance, higher IQ and 
reduced symptoms of expression and motivation provide support for theta playing a fundamental role in 
PFC-dependent attentional processing and cognitive control. Consistent with these results, theta has 
previously been reported to be associated with superior working memory and executive functioning 
(Berger et al., 2016), to support higher working memory load (Jensen and Tesche, 2002), and to 
implement ER strategies (Ertl et al., 2013). Accordingly, theta oscillatory activity may be a critical 
neurobiological marker for frontal integrity and PFC-dependent cognitive symptoms of psychopathology. 
However, a spontaneous predominance of slow-wave (i.e., theta) activity relative to fast-wave (i.e., beta) 
has been proposed to underlie inferior cortical control over subcortical affective processes at rest 
(Morillas-Romero et al., 2015; Schutter et al., 2006). The inconsistent results most likely result from 
different theta measurements (i.e., induced phase-invariant or evoked phase-locked) and collection 
parameters (spontaneous activity at rest, or due to task manipulation).  
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 Following stress exposure, frontal theta activity increased, especially for aversive stimuli. 
Heightened tonic theta activity has been proposed to underlie deficient regulation of brain arousal, 
indicating that greater frontal theta activity following stress may reflect the elevated arousal state and the 
weakened regulation of brain state (Arns and Kenemans, 2014; Morillas-Romero et al., 2015). Consistent 
with these results, enhanced theta activity is found to accompany increasing task demands (Jensen and 
Tesche, 2002), which are considered stressful in experimental settings (Allen et al., 2014), and to 
subserve cognitive reappraisal in emotion regulation paradigms (Ertl et al., 2013). Stress has been 
reported to reduce frontal midline theta oscillations during working memory tasks (Gärtner et al., 2014), 
yet the effect of stress on electrophysiological correlates of ER has not been previously reported. While 
PFC-dependent working memory is impaired and associated theta is reduced under stressful conditions, 
acute stress exposure heightens arousal state, possibly promoting exaggerated attention to, and 
cognitive processing of, emotional events, reflected in the increased theta observed in the current study. 
Consequently, stress may modify theta differently according to the task employed. However, it is also 
possible that the discrepancy in results could be accounted for by the method of extracting theta power. 
The current study examined non-phase locked changes in spectral power with respect to event onset, 
whereas, Gärtner and colleagues extracted phase-locked event-related changes in EEG power, which 
may explain the different results. Consistent with increased theta accompanying greater workload and 
successful ER, increased theta may also represent a compensatory mechanism to allow for the 
challenging implementation of ER strategies under stressful conditions and increased arousal states.  
Along with frontal theta deficiencies, SCZ patients also expressed aberrant parietal beta activity, 
with weakened beta desynchronization in response to aversive stimuli, consistent with previous reports of 
beta ERD and emotional processing in SCZ (Csukly et al., 2016). The reduced beta ERD in patients 
possibly reflects impaired engagement and connectivity within the insula-centered salience network, and 
disruptions in the delicate balance of excitatory and inhibitory activity. Beta oscillatory activity signals the 
initial requirement for heightened attentional resources for novel or salient stimuli to prepare the shift to a 
gamma-dominated attention state (Wróbel 2000). Furthermore, beta activity is associated with stimulus-
driven salience (Kisley and Cornwell, 2006), and increased beta activity has been found in response to 
negative valence high arousal eliciting images (Güntekin and Başar, 2010) and angry faces (Güntekin 
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and Basar, 2007) during a passive viewing task, and for relevant target images (Güntekin et al., 2013). 
The stronger beta ERD for aversive stimuli relative to neutral stimuli found in the current study may 
support appropriate stimulus attribution and motivated attention, and is consistent with previous research 
(Csukly et al., 2016). For control participants, enhanced parietal beta ERD for aversive stimuli in the 
emotional framing paradigm may have prevented alternative processes from interfering with the frontal 
engagement required to appropriately process the stimuli according to the framing context. Additionally, a 
magnetoencephalography (MEG) study found that SCZ patients revealed an atypical increase in beta 
activity in the insula for irrelevant stimuli, further supporting beta’s imperative role in salience processing 
and dysfunction of the salience network in schizophrenia (Liddle et al., 2016). In SCZ patients, aberrant 
beta activity may disrupt the initial detection and attribution of salience, causing impaired perceptual 
integration, deficient evaluation of stimuli and inappropriate response selection.  
Furthermore, neurotransmitter systems, including dopamine and GABA, are proposed to 
coordinate beta activity, suggesting that aberrant beta activity may reflect disruptions in neurotransmitter 
systems. Dopamine is of particular interest for its role in modifying beta activity to support coordination of 
neural activity in cortical-basal ganglia networks (Jenkinson and Brown, 2011; Leventhal et al., 2012). 
Consequently, hyperdopaminergic transmission in SCZ may influence beta activity, causing abnormal 
salience attribution and distorted perceptions of reality. Along with salience processing, beta is associated 
with inhibitory cortical transmission; therefore, the weakened beta desynchronization observed in the 
current study may indicate a disruption in the excitability-inhibitory balance, mediated by GABAergic 
interneuron transmission, resulting in heightened neural excitability (Liddle et al., 2016). Aberrant beta 
activity exhibited in patients may indicate inferior GABAergic transmission, as GABA is responsible for 
generating beta oscillations (Liddle et al., 2016).  
Following stress exposure, neutral stimuli evoked reduced parietal beta ERD for both groups, 
indicating a disruption in salience attribution and arousal, and is consistent with aberrant limbic activation 
following stress in neuroimaging studies (Oei et al., 2012). Increased beta has been reported in response 
to sleep deprivation and the Stroop test when used as experimental stressors (Alonso et al., 2015), and 
during a noise stressor (Banis et al., 2014), which along with the current findings, implicate beta in 
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regulating arousal state. Impaired neural regulation of the vagal brake and the inability to alter visceral 
state, indexed by reduced RSA and HP and increased HR, was related to weakened beta ERD. The 
heightened beta excitability (reflected in reduced ERD) may be suggestive of a maladaptive arousal state 
before stress, which was further associated with increased motivation and pleasure symptoms, and 
positive symptom severity in SCZ patients. The relationship between RSA, executive function and social 
engagement has been demonstrated previously (Appelhans and Luecken, 2006; Hamilton et al., 2014; 
Hansen et al., 2003, 2004; Lane et al., 2009; Porges, 2007); however, to my knowledge, this is the first 
study to confirm a relationship between aberrant stress reactivity, clinical symptom severity and 
dysregulated electrophysiological correlates of affective processing. In addition to supporting 
inappropriate mobilization and defensive behaviors, a maladaptive stress response may subserve 
impaired oscillatory activity, which compromises the integration of neural information, shifts the excitatory-
inhibitory balance, and ultimately results in network dysconnectivity and cognitive and behavioral 
interference. Aberrant beta activity may reflect a global brain state of heightened arousal, potentially 
caused by maladaptive stress regulation exhibited in patients in the absence of stress or in response to 
acute stress exposure, which interferes with top-down, slow-wave dominated frontal processes (Engel 
and Fries, 2010).  
External representations of the environment are processed through the central autonomic 
network, comprised of frontal and limbic regions, including PFC, ACC, insula and amygdala, which 
interact with visceral afferents conveying information of internal physiological states to adjust arousal and 
select appropriate behavioral and emotional responses (Benarroch, 1993). Additionally, a significant 
coupling between natural cortisol perturbations and beta activity is reported, indicating an intricate 
relationship between the HPA stress system and oscillatory regulation of arousal state (Chapotot et al., 
1998). The relationship between deficient frontal theta, aberrant parietal beta and maladaptive 
physiological measures of stress may reflect a compromised interface of the central autonomic network 
and visceral afferents to regulate autonomic flexibility. Furthermore, the insula has a proposed role in 
coordinating autonomic, visceral and homeostatic states, and the subjective experience of salience, 
providing additional evidence that beta abnormalities may subserve the atypical insula connectivity and 
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activation patterns found in schizophrenia (Palaniyappan et al., 2012b; Uddin, 2015; Wylie and Tregellas, 
2010).  
A number of limitations should be addressed in future studies. Notably, the current study 
restricted recruitment to males because of the significant interaction between gonadal and stress 
systems, sex differences in the psychosocial stress response (Foley and Kirschbaum, 2010; Kirschbaum 
et al., 1992), and sex disparities in the neural correlates of affective processing (Gardener et al., 2013; 
Stevens and Hamann, 2012; Whittle et al., 2011). Extensive sex differences in neural correlates of 
affective processing have been reported, including enhanced negative emotionality in females, thus 
representing the importance of considering sex in elucidating the neurobiological substrates of emotion 
(Gardener et al., 2013; Stevens and Hamann, 2012). Furthermore, it has been demonstrated that men 
and women differentially respond to emotion regulation strategies following stress exposure, suggesting 
that the interaction between stress and sex influences emotion regulation ability (Kinner et al., 2014; 
Kogler et al., 2014). Despite the profound interest in examining the interaction between sex, stress and 
emotion, the current study did not have sufficient subject numbers to control for sex, let alone menstrual 
cycle phase and contraceptive use. Elucidating sex differences in the interaction between stress and 
affective processing would be crucial for developing gender-unbiased, novel treatment approaches.  
As mentioned previously, the emotional oddball framing paradigm did not produce a significant 
effect of framing. The emotional oddball framing paradigm has been reported previously to reliably down-
regulate the LPP response to aversive stimuli with positive contextual cues in healthy college students 
(Kisley et al., 2011); however, there are several notable differences in the task design which could 
account for the discrepancy in results. The initial study (Kisley et al., 2011) was a between-subjects 
design, where the participants were either assigned to a positive or negative condition, and included 
positive images in the task design. I chose to eliminate the positive images because there are no 
significant framing effects found for positive stimuli and ER effects are stronger for aversive stimuli (Kisley 
et al., 2011). Additionally, the current study used 120 neutral and aversive target stimuli in contrast to the 
30 (6 target) images used in the initial study, which could have contributed to the heightened P3 
amplitude for neutral stimuli. Future studies could implement an alternative ER paradigm requiring more 
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cognitive effortful reappraisal strategies to regulate emotional response, such as the task used in Strauss 
et al., 2013. While there were no significant framing effects in the current study, differential responses to 
aversive and neutral stimuli before and after a stress manipulation were still examined. Additionally, SAM 
ratings were not given after each framing condition because of time constraints; however, this repeated 
SAM administration would be necessary to determine any differences in arousal and valence ratings due 
to the framing or stress manipulation. 
Future studies examining stress effects on electrophysiological correlates of affective processing 
should include the analysis of intertrial phase coherence as an additional measure of neural synchrony. 
Source localization methods and concurrent fMRI-EEG studies could also be employed to further define 
the anatomical substrates of the EEG oscillatory activity. The effect of stress on resting EEG state is still 
being explored and will provide evidence for differential effects of stress on spontaneous and evoked 
theta and beta activity.  
Finally, medication exposure, smoking and caffeine consumption, and body-mass-index are all 
thought to modify peripheral autonomic output. While participants were instructed to refrain from smoking 
and consuming caffeine prior to the study session, these behaviors could have influenced heart rate 
parameters of stress reactivity. Medication exposure is a common issue in studies with SCZ patients as it 
is challenging to disentangle the medication effects from the experimental results without restricting 
medication use. However, high-potency antipsychotics and novel agents used by the majority of patients 
have only minimal effects on heart rate parameters, consequently, it seems unlikely that the current 
physiological results are attributable to medication use (Bar et al., 2005; Boettger et al., 2006). Despite 
evidence that medication exposure alters ERP components (Coburn et al., 1998; Gonul et al., 2003), 
oscillatory dysfunction, at least in gamma frequency, seems to be maintained regardless of medication 
status (Gallinat et al., 2004). Future studies could look at first-episode psychosis with patients without 
chronic medication exposure to further understand the influence of anti-psychotic medications on 
oscillatory activity, or investigate first-degree relatives to determine vulnerability.  
Oscillations and their synchronization are important mechanisms by which brain regions interact, 
therefore, providing a valuable tool for elucidating the efficiency of fronto-limbic circuitry in regulating 
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affective and stress responses. This is the first study, to my knowledge, to investigate electrophysiological 
correlates of affective network efficiency following a stress manipulation in patients with SCZ. Advancing 
the understanding of neural mechanisms underlying ER and the stress response and how they interact 
provides valuable insight on homogeneous symptom dimensions shared across neuropsychiatric 
disorders. The relationship between aberrant EEG indices of ER, impaired stress reactivity and enhanced 
symptom severity may motivate future studies to examine therapeutic and intervention approaches 
targeting stress and ER to alleviate symptom pathology or prevent the precipitation of symptoms in 
vulnerable individuals. Stress mediation, for instance, may be an effective supplemental treatment option 
to complement existing cognitive therapies, including those reliant on ER, to alleviate persistent negative 
and cognitive symptoms. 
3.3 Future Directions 
To further elucidate the effect of stress on the integrity of fronto-limbic oscillations and efficiency 
of the circuitry to respond and adapt to stress, future studies could analyze the resting state EEG 
recordings directly before and immediately after the stress manipulation and at the termination of the 
session. Using frequency decomposition to extract spontaneous theta and beta power, the slow wave – 
fast wave (theta/beta) ratio could be evaluated during the resting state recording before and after the 
stress manipulation, and compared to previous studies suggesting that high ratios may reflect a 
motivational imbalance in cortical control and subcortical affective networks (Morillas-Romero et al., 
2015). Additional examination of cross-frequency coupling between slow and fast frequencies during 
resting state and during the emotional oddball framing paradigms would be informative in understanding 
the regulation of cortical state and maintenance of the dynamic excitatory-inhibitory balance. 
Furthermore, separating theta and beta frequencies into high and low components could also help refine 
the contribution of each band.  
While the current project focused on the influence of stress on theta and beta oscillatory activity 
for their roles in salience and affective processing, it would be interesting to expand the research scope 
and investigate changes in alpha activity due to stress. Alpha has been related to inhibition of task-
irrelevant processing and maximal over occipital cortex during relaxed state (Uhlhaas et al., 2008). 
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However, frontal alpha asymmetry has also been examined as an important index for affective state and 
efficient arousal and regulation. Goodman and colleagues (2013) found that elevations in alpha 
asymmetry were associated with weakened eye-blink startle response (proposed to underlie ER) during 
heightened stress situations. In addition to extracting ERSP, which is time-locked but not phase-locked, 
future studies could also evaluate phase-locked event-related evoked power and phase consistency or 
intertrial (phase) coherence (ITC), an additional measure of neural synchrony (Roach and Mathalon, 
2008) to further characterize oscillations and their synchronization in patients with SCZ. Cross-channel 
coherence can be used to examine oscillatory consistency or connectivity between scalp locations, 
especially between frontal and parietal locations, or between cortical and subcortical sources of the EEG 
signal using source localization algorithms.  
Salivary cortisol and alpha amylase were collected throughout the EEG session to monitor stress 
reactivity and HPA axis function; however, data were not analyzed because of financial limitations. 
Cortisol and alpha amylase would provide crucial information to characterize the stress response as 
cortisol is released in response to HPA stimulation and alpha amylase is an index of sympathetic system 
activity, not currently assessed with the physiological heart rate parameters.   
Results from the current study provide valuable information about the oscillatory activity 
underlying affective and salience processing and how they are affected by stress in SCZ patients and 
healthy controls. However, the emotional oddball framing paradigm did not produce reliable neural 
regulation of the electrophysiological response to aversive stimuli. Future studies could employ a more 
robust cognitive reappraisal task, similar to Horan and colleagues (2013), to establish differences in ER 
and determine if acute psychosocial stress would influence the ability to utilize ER strategies and the 
electrophysiological correlates underlying ER. It would also be interesting to administer an emotional go-
no-go task before and after the TSST stressor to elucidate the affective interference on cognitive 
processing and inhibition processes.  
While this study was limited to males with schizophrenia, deficiencies in ER are not unique to 
schizophrenia and span multiple neuropsychiatric disorders. The current study protocol, with the stressor 
sandwiched between two ER tasks, could be applied to other neuropsychiatric disorders and during 
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pivotal stages of development to investigate the impact of stress on implementing emotion regulation 
strategies, integral to the effectiveness of cognitive behavioral therapy. Moreover, this protocol should be 
applied to women with schizophrenia in order to examine sex-dependent disparities in stress reactivity 
and its effect on electrophysiological correlates of affective processing. Despite the important revelations 
of the current study in demonstrating the deficiency of fronto-limbic neural oscillatory activity and 
maladaptive stress responses in patients with schizophrenia revealed in the current study, there are still 
many unanswered questions that excite further research exploration. 
3.4 Significance 
Cognitive behavioral therapy is a fundamental therapeutic approach for alleviating the persistent, 
debilitating negative and cognitive symptoms of SCZ, and it is reliant on emotion regulation strategies that 
are more difficult to implement under stress. This is the first study to elucidate the effects of stress on the 
electrophysiological correlates of emotional framing, assessing an important aspect of ER, in SCZ 
patients and controls to identify therapeutic targets for improving treatment efficacy. The study advances 
the understanding of neural mechanisms underlying ER and the stress response and how they interact, 
and it provides valuable insight on homogenous symptom dimensions shared across multiple 
neuropsychiatric disorders. Furthermore, the study confirmed that theta oscillatory dysfunction is a 
potential biomarker for frontal impairment, while beta activity may index an excitatory-inhibitory imbalance 
promoting aberrant salience processing. These neurophysiological biomarkers may be useful in future 
studies examining innovative therapeutic and intervention approaches targeting stress and ER to alleviate 
symptom pathology and prevent the precipitation of symptoms in vulnerable individuals. Specifically, 
results suggest that therapeutic approaches targeting the stress response, including mindfulness training 
and stress mediation therapy, may restore fronto-limbic oscillatory activity to facilitate cognitive therapies, 
and may be valuable in combating resistant negative and cognitive symptoms of schizophrenia. 
Oscillations at different frequencies reflect global cortical state, suggesting that transcranial magnetic 
stimulation (TMS) or transcranial current stimulation (TCS) may manipulate oscillatory activity to 
encourage effective neural processing. Targeting theta and beta activity therapeutically may improve 
fronto-limbic efficiency and support the cognitive therapies reliant on ER to ameliorate symptom severity. 
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Chapter 3.2 Tables 
Table 3.1. Demographic and Clinical Characteristics of Study Groups 
  SCZ Patients CON group  Statistic 
Demographic Information (N=21) (N=21)   
Age 25.81 ± 4.25 23.81 ± 4.61 F(1,41) = 2.14 
Handedness (r/l) 17/4 18/3 F(1,41) = 0.16 
Education (years) 13.24 ± 1.76 15.24 ± 1.64 F(1,41) = 14.53** 
Avg parental education (years) 15.38 ± 2.38 15.89 ± 2.71 F(1,33) = 0.34 
Race Χ2(3) = 7.13 
White 9 11 
Black 11 4 
Asian 1 5 
Hispanic 0 1 
Clinical       
CAINS-MAP 10.53 ± 5.94 2.39 ± 3.20 F(1,34) = 25.89** 
CAINS-EXP 2.82 ± 3.11 0.44 ± 0.78 F(1,34) = 9.90* 
Illness Duration 6.11 ± 5.23 
PANSS (total score) 57.90 ± 14.80 
Positive subscale 15.05 ± 5.07 
Negative subscale 14.05 ± 4.63 
General subscale  28.8 ± 7.72  
Drug & Alcohol Use (AUS/DUS)       
Tobacco 1.0 ± 1.10 0.58 ± 0.84 F(1,34) = 1.66 
Alcohol 1.10 ± 1.24 1.84 ± 1.38 F(1,34) = 3.03 
THC 0.94 ± 1.73 0.79 ±1.23 F(1,34) = 0.09 
Abbreviations: CAINS-MAP: Clinical Assessment Interview for Negative Symptoms- Motivation and 
Pleasure Scale; CAINS-EXP: CAINS-Expression Scale; PANSS: Positive and Negative Syndrome Scale 
*P < 0.05. **P < 0.001. 
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Table 3.2. Neurocognitive Assessments and Questionnaires 
SCZ Patients CON Group Statistic 
Neurocognitive Assessments       
CPT-IP (Avg D-Prime) 2.73 ± 0.96 3.38 ± 0.64 F(1,37) = 6.00* 
NAART (# of words) 29.55 ± 11.88 45.2 ± 6.99 F(1,39) = 25.80** 
Visuospatial Sequencing Test (tot. correct) 15.38 ± 3.07 18.81 ± 2.68 F(1,41) = 14.86** 
Auditory Verbal Learning Test (tot. recalled) 21.16 ± 5.95 28.89 ± 5.17 F(1,37) = 18.31** 
Auditory Verbal Learning Test (tot. rec. after delay) 11.67 ± 3.00 14.05 ± 1.07 F(1,41) = 11.693* 
Stroop Interference Scorea 9.40 ± 7.73 3.71 ± 2.53 F(1,41) = 10.27* 
Questionnaires       
Perceived Stress Scaleb 17.50 ± 7.01 15.05 ± 4.96 F(1,38) = 1.62 
Daily Stress Inventoryc 2.83 ± 1.30 2.67 ± 0.84 F(1,38) = 0.21 
ERQ Reappraisald 27.05 ± 7.62 29.95 ± 6.45 F(1,39) = 1.70 
ERQ Suppressione 14.79 ± 3.60 13.86 ± 5.85 F(1,39) =0.36 
Abbreviations: CPT-IP: Continuous Performance Test- Identical Pairs, Average Sensitivity Index (D’) for 
2,3, and 4 digit trials; NAART: North American Adult Reading Test; ERQ: Emotion Regulation 
Questionnaire 
a Stroop interference score = colored words – colored squares 
b Perceived Stress score reflects sum of all scale items 
c Daily Stress score is the average impact rating of endorsed events 
d ERQ Suppression items: 2,4,6,9 
e ERQ Reappraisal items: 1,3,5,7,8,10 
 
*P < 0.05. **P < 0.001. 
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Table 3.3. Emotional Oddball Framing Paradigm: Behavior and SAM ratings 
 
SCZ Patients Controls 
Aversive Neutral Aversive Neutral 
Behavior         
Latency (ms)(Mean ± SD) 
Neutral Framing Condition 535.65 ± 226.18 534.40 ± 202.04 468.61 ± 280.58 428.58 ± 287.74 
Negative Framing Before Stress 645.50 ± 334.92 756.32 ± 464.93 500.65 ± 305.93 614.51 ± 459.50 
Positive Framing Before Stress 550.69 ± 276.20 702.27 ± 305.42 385.39 ± 243.13 535.49 ± 253.15 
Negative Framing After Stress 477.37 ± 313.61 517.81 ± 286.63 401.14 ± 232.05 405.21 ± 166.89 
Positive Framing After Stress 520.97 ± 373.40 546.12 ± 304.91 386.36 ± 302.93 449.17 ± 175.32 
Accuracy (% correct) 
Negative Framing Before Stress 85.00 ± 14.34 82.59 ± 13.79 88.84 ± 10.00 84.60 ± 8.27 
Negative Framing After Stress 85.19 ± 17.54 79.07 ± 10.28 90.79 ± 7.67 77.94 ± 10.08  
SAM Rating (Mean ± SD)         
Valence 2.30 ± 0.96 4.99 ± 1.41 2.84 ± 0.85 4.99 ± 0.68 
Arousal 3.63 ± 1.41 3.20 ± 1.77 4.63 ± 1.82 3.22 ± 1.71 
 
Abbreviations: SAM: Self-assessment manikin 
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Chapter 3.2 Figures  
Figure 3.1. Emotional Oddball Framing Paradigm 
 
 
Schematic diagram showing a representative block from each of the three framing conditions with a 
neutral or aversive target embedded among four neutral stimuli. Each stimulus was presented for 1000 
ms followed by a framing cue. Participants were instructed to categorize the image according to the 
framing cue using a button box. 
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Figure 3.2. Diagram of Study Design 
 
 
Timeline of the EEG session. Session started at 1:00 PM for all participants. Order of emotional framing 
tasks was counterbalanced between participants. TSST: Trier Social Stress Test; SAM: Self-assessment 
manikin 
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Figure 3.3. Summary of Neurocognitive and Clinical Measures 
 
 
Summary of the outcome variables collected at the clinical and neurocognitive and EEG sessions. 
Calculation of composite scores is described. 
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Figure 3.4. Electrode Map of Parietal Montage 
 
Electrode map highlighting the four parietal electrodes (Pz (62), 71, 72, 76) comprising the parietal cluster 
that was used to analyze average ERP amplitudes. 
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Figure 3.5. Subjective Stress and Affect Ratings 
 
A. Subjective stress and affect ratings (SSR) collected at six time-points throughout the EEG session 
to monitor changes in affect following the stress manipulation. Five affect categories were assessed 
(Stressed, Happy, Irritated, Depressed, Overwhelmed). Controls on the left, SCZ patients on the right. 
B. PANAS affect ratings collected at the beginning (Before Stress) and end (After Stress) of EEG 
session to look at changes in negative and positive affect. Controls are represented by the gray bars 
and SCZ patients are represented in blue. 
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Figure 3.6. Physiological Measures of Stress  
 
Heart rate parameters collected before (rs1), during (TSST-prep, TSST-speech, TSST-math) and 
following stress exposure (rs2, rs3). Controls are represented in gray, SCZ patients in blue. A. Average 
heart period measured in ms. SCZ patients exhibited a blunted heart period response relative to controls. 
B. Average heart rate measured in beats per minute (bpm). Group difference in quadratic contrast was 
found. C. Respiratory Sinus Arrhythmia (RSA) measured in ln ms2. D. RSA before stress, during stress 
and after stress. SCZ patients revealed reduced RSA before stress and a significant group difference in 
slope was observed. 
*P < 0.05.  
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Figure 3.7. Valence Discrimination during Neutral (Animal) Framing Condition 
 
Grand average waveforms for control participants (A) and SCZ patients (B) averaged across the parietal 
electrode cluster in response to neutral targets (dashed blue line) and emotional targets (solid blue line). 
Gray boxes indicate analysis window for P3 (250-500 ms) and LPP (400-1000 ms). Average P3 and LPP 
amplitudes for aversive stimuli were greater than neutral stimuli, indicating intact valence discrimination. 
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Figure 3.8. ERP Amplitudes Elicited During the Different Framing Conditions Before and After 
Stress 
 
Grand average waveforms from the parietal cluster for control participants (left) and SCZ patients (right) 
during negative (black) and positive (red) framing conditions for neutral (dashed lines) and emotional 
(solid) target stimuli. Gray boxes indicate analysis windows, P3 (250-500 ms) and LPP (400-1000 ms). A. 
P3 and LPP waveforms before stress. B. P3 and LPP waveforms after stress. C. Graphical representation 
of framing effects on average LPP amplitude. Black is negative framing condition and red is positive 
framing condition, with controls on the left and SCZ patients on the right. D. Framing effects on average 
P3 amplitude. 
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Figure 3.9. Early Frontal Theta Activity Before Stress 
 
Time-frequency spectrograms show event-related changes in theta (4-8 Hz) ERSP (event-related spectral 
perturbation, dB) at Fz electrode following emotional and neutral targets during neutral, positive and 
negative framing conditions before stress (stimulus onset = time 0 ms). Controls are on the left and SCZ 
patients are on the right. SCZ patients exhibited significantly reduced theta activity for emotional targets 
during the positive and negative framing conditions. 
*P < .05.  
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Figure 3.10. Stress Reactivity Induced Changes in Early Frontal Theta ERSP 
 
A. Time-frequency spectrograms depict frontal midline (Fz) theta (4-8 Hz) ERSP (event-related spectral 
perturbation, dB) for emotional and neutral targets collapsed across emotional framing condition before 
and after stress. Stress exposure increased theta activity, especially for emotional stimuli. B. Graphical 
representation of negative (black) and positive (red) framing effects on average early theta (100-500 ms) 
measured from Fz electrode. Controls on the left, SCZ patients on the right. 
*P < 0.05.  
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Figure 3.11. Late Parietal Beta Activity Before Stress 
 
 
Time-frequency spectrograms show parietal (Pz) beta (13-30 Hz) ERD (event-related desynchronization, 
dB) for emotional and neutral targets during neutral, positive and negative framing conditions before 
stress (stimulus onset = time 0 ms). Controls on the left, SCZ patients on the right. Beta ERD was 
stronger for aversive stimuli relative to neutral stimuli. SCZ patients demonstrated weakened beta ERD 
for emotional stimuli compared to controls.  
*P < 0.05.  
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Figure 3.12. Changes in Late Parietal Beta Activity Following Stress 
 
A. Time-frequency spectrograms show average parietal (Pz) beta (13-30 Hz) activity for emotional and 
neutral targets collapsed across emotional framing conditions before and after stress. B. Graphical 
representation showing average late (600-1000 ms) parietal beta ERD (event-related desynchronization) 
for neutral, and negative and positive framing conditions before and after stress. Beta ERD was stronger 
for aversive stimuli before and after stress. Beta ERD was reduced for neutral stimuli following stress. 
Controls are represented in gray, SCZ patients are in blue. Light colors represent neutral stimuli and dark 
colors represent emotional stimuli. 
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Figure 3.13. Relationship between Physiological Measures of Stress, Clinical and Neurocognitive 
Assessments, and EEG Activity in SCZ Patients. 
 
 
Spearman’s rank correlations for SCZ patients demonstrate relationships between clinical, 
neurocognition, stress and neurophysiology. A. Reduced frontal theta activity before stress is associated 
with increased CAINS motivation and pleasure symptom severity. B. Reduced frontal theta activity before 
stress is related to inferior memory performance. C. Reduced RSA before stress is associated with 
greater parietal beta. D. More severe positive symptoms were related to lower heart period before stress.  
RSA: Respiratory Sinus Arrhythmia; CAINS: Clincial Assessment Interview for Negative Symptoms; 
PANSS: Positive and Negative Syndrome Scale.  
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CHAPTER 4: CONCLUSIONS 
Maladaptive stress and arousal regulation and exaggerated limbic recruitment in patients with 
schizophrenia may interfere with effective frontal engagement, promoting aberrant perceptual integration, 
inappropriate salience attribution, deficient cognitive control and devastating symptom pathology. Results 
from the current study suggest that neural connectivity dysfunction and compromised fronto-limbic 
circuitry are further exacerbated by stress in patients with schizophrenia. Important findings from 
Experiment 1 and 2 are summarized in the following sections, including a discussion of the aberrant 
salience, fronto-limbic deficiencies and dysregulated stress reactivity observed in schizophrenia patients 
and how these affective and stress systems interact to promote symptomatology.  
4.1 Support of Schizophrenia as a Salience Syndrome 
The debilitating disruptions in salience processing observed in patients with SCZ is reflected in 
aberrant beta activity, which interacts with neurotransmitter systems including dopamine, to regulate 
cortical state and support the integration of information in the salience network. Heightened beta activity, 
observed in patients for task-relevant aversive stimuli, and for irrelevant salient stimuli in individuals at 
familial high-risk, may indicate deficiencies of the salience network to support the attentional resources 
necessary for processing evocative stimuli, resulting in reduced electrophysiological correlates of 
motivated attention to salient distractors (early LPP) and reduced frontal theta. Interestingly, symptom 
naïve first-degree relatives (FDR) exhibited a unique enhancement of the late LPP amplitude and beta 
activity in response to irrelevant aversive distractors, possibly representing a compensatory mechanism 
which recruits alternative salience regions to enhance the allocation of attention, and allows FDR 
participants to achieve a behavioral performance equivalent to controls. Additionally, patients with SCZ 
demonstrated paradoxical behavioral responses for neutral and aversive stimuli, with increased latency 
responses for neutral stimuli and reduced latency for aversive stimuli, further indicative of inappropriate 
salience and attribution of motivational significance to irrelevant, neutral stimuli. Beta oscillations are 
thought to be generated by GABAergic transmission, suggesting a pivotal role of GABA-derived beta 
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activity in maintaining an appropriate excitatory-inhibitory balance. Therefore, weakened beta 
desynchronization may reflect enhanced neural excitability, which in turn, interrupts attentional tuning and 
signal to noise discrimination which are reflected in the reduced early LPP amplitudes in patients and 
FDR. Thus, beta oscillatory activity, along with early LPP, may be important neurophysiological markers 
for psychosis. Salience dysfunction interferes with cognitive processes essential for social engagement 
and goal-oriented behaviors, and may underlie positive and negative symptoms of schizophrenia.  
4.2 Insights into Fronto-Limbic–Dependent Affective Processing                                       
Impairments in Patients with Schizophrenia 
The disproportionate recruitment of limbic activity observed in patients with schizophrenia 
subserves heightened affective interference, further blunting frontal engagement and disrupting response 
selection. Despite intact novelty detection in schizophrenia and FDR (P3a) and appropriate valence 
discrimination (greater neural correlates for aversive relative to neutral stimuli), patients exhibit aberrant 
attentional processing of affective information, reflected in the reduced early LPP and theta activity during 
the emotional oddball paradigm, and reduced theta activity during the processing of aversive stimuli 
during the emotional framing paradigms. Theta activity plays a critical role in coordinating attentional 
resources and provides a foundation for frontal mediated function (Ertl et al., 2013; Gärtner et al., 2014). 
Furthermore, the successful integration of neural information processed in remote brain regions 
supporting global cortical communication relies on efficient theta oscillations and their synchronization. 
Therefore, deficient theta activity may represent global dysconnectivity with abnormal neuronal 
participation and synaptic connectivity. Specifically, inferior frontal theta activity elicited during the framing 
tasks in SCZ patients may reflect deterioration of frontal integrity, consistent with neuroimaging reports of 
structural and functional impairments of frontal lobe and its connectivity in patients with SCZ. Given these 
results, theta may be considered a neurophysiological marker for frontal network function. 
4.3 Insights into Impaired Stress Reactivity in Patients with Schizophrenia 
SCZ patients exhibited a maladaptive stress response, suggestive of deficient autonomic 
flexibility and neural regulation of visceral state. In addition to an elevated baseline arousal state with 
increased heart rate and reduced heart period and RSA, patients demonstrated a unique progression in 
RSA from baseline to recovery and blunted stress reactivity to an acute psychosocial stressor. This was 
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the first study, to my knowledge, that examined RSA over a prolonged period in response to and recovery 
following a psychosocial stressor in SCZ patients. Results suggest that patients are unable to suppress 
RSA following stress exposure, which may underlie maladaptive behavioral consequences. Furthermore, 
the failure to suppress RSA has important implications for maladaptive behavioral responses, including 
social engagement, executive functioning, and symptom pathology (Porges, 2007). The maladaptive 
stress response in patients possibly contributes to heightened neural excitability, the exaggerated 
recruitment of limbic networks and impaired frontal engagement, further interfering with appropriate 
salience attribution and affective processing.  
4.4 Disruption of Fronto-Limbic Oscillatory Indices of Salience and                                        
Affective Processing Following Stress Exposure 
Stress modified electrophysiological correlates of affective processing and disrupted fronto-limbic 
oscillatory activity reflected in less efficient frontal theta activity and elevated beta excitability for all 
participants. Deficiencies in beta and theta oscillatory activity in patients with SCZ, were further 
exasperated following the stress manipulation. Results suggest that a maladaptive stress response may 
impair oscillatory activity, compromise neural integration, disrupt the excitatory and inhibitory balance, 
and promote network dysfunction in patients with schizophrenia. Accordingly, an aberrant baseline stress 
and arousal state in patients with SCZ, with maladaptive physiological measures of stress, was 
accompanied by opposing disruptions in frontal theta and beta excitability. This enhanced state of 
arousal, with enhanced beta excitability and physiological stress, may reflect exaggerated limbic 
recruitment, thus interfering with frontal allocation of attentional and cognitive resources to process 
information, especially emotionally salient stimuli. Additionally, aberrant beta activity was related to 
atypical stress responses and elevated symptom severity, reflecting the inability to regulate visceral state 
in patients with SCZ, which may interfere with frontal recruitment, and impede the successful employment 
of emotion regulation strategies. The heightened stress profile, elevated neural excitability and 
deterioration of frontal integrity observed in SCZ patients is not conducive for effective perceptual 
integration and cognitive regulation at baseline, let alone during stress exposure. Not surprisingly, stress 
appears to impact the efficiency of affective processing by disrupting frontal efficiency and arousal 
regulation. Furthermore, maladaptive stress responses were associated with impaired executive function, 
101 
 
enhanced negative symptom severity and psychosis. This is the first study to define the relationship 
between aberrant stress reactivity, clinical and neurocognitive measures, and dysregulated 
electrophysiological correlates of salience and affective processing in patients with schizophrenia and 
healthy controls. Results from these experiments have significant potential for identifying novel 
physiological biomarkers for the early detection and prediction of psychosis. Furthermore, results suggest 
that modifying fronto-limbic oscillatory activity by targeting the stress response may be effective for 
improving efficiency of fronto-limbic circuitry, critical for emotion regulation-dependent therapies. 
4.5 Final Thoughts 
 Aberrant salience attribution, disturbances in perceptual integration and maladaptive brain state 
regulation are a result of insula dysfunction and are core deficits of schizophrenia, designating the insula 
as fundamental to the pathophysiology of schizophrenia. As a critical node in the salience network, the 
insula coordinates perceptual, internal emotional and physiological state information to appropriately 
motivate attention and promote adaptive behaviors (Uddin, 2015). Not only do patients with schizophrenia 
exhibit anatomical (Fornito et al., 2009; Glahn et al., 2008; Kasai et al., 2003; Shepherd et al., 2012) and 
functional (Li et al., 2010; van der Meer et al., 2014) abnormalities in the insula, they demonstrate 
neurophysiological correlates of insula dysfunction, including elevated beta activity. Adding to the 
significance of insula dysfunction in the etiology of schizophrenia is the fact that a unique type of 
evolutionary specific neurons with a characteristic spindle shape, referred to as Von Economo neurons, 
are specifically localized in the insula-dominated salience network and are critical for relaying information 
over long distances to govern network switching processes (Butti et al., 2013). Schizophrenia patients 
exhibit a reduced number of Von Economo neurons (Brüne et al., 2010), further highlighting the salience 
network as playing a critical role in the development, maintenance and treatment of 
neuropsychopathology. Results from Experiment 1 and 2 provide further evidence that the aberrant 
affective and stress regulation which is observed in schizophrenia patients may revolve around a central 
deficit in the insula-mediated salience network. 
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